Home Blog Page 42

‘Laughable’ alcohol responsibility deal has worsened nation’s health, says charity

Katherine BrownThe government’s controversial public health responsibility deal for alcohol has pursued initiatives ‘known to have limited efficacy’ while obstructing more meaningful action, according to a damning report from the Institute of Alcohol Studies (IAS). If the industry has used the deal to resist more effective measures, the deal may even have ‘worsened the health of the nation’.

The deal – a partnership between the government, drinks industry and voluntary sector – was first announced five years ago as part of the public health white paper (DDN, 6 December 2010, page 4). It was subsequently dismissed by Alcohol Concern as ‘the worst possible deal for everyone who wants to see alcohol harm reduced’ (DDN, April 2011, page 4), with the charity one of a number of bodies – including the Royal College of Physicians and British Medical Association – that refused to sign up.

The boycott meant that the deal was never a ‘genuine partnership’, says the document, with many of the organisations’ objections ‘vindicated in the four years since’. Implementation of the deal’s non-binding pledges – a new set of which were announced last summer (DDN, August 2014, page 4) – has frequently ‘failed to live up to the letter and/or spirit’, says the report, with ‘ambiguous’ goals and poor reporting practices also rendering any evidence on the deal’s effectiveness ‘limited and unreliable’.

The document also casts doubt on the deal’s future, as the government has not explicitly committed to its renewal since the election, and the partnership’s ‘alcohol network’ has not met in more than a year. IAS is calling for the deal to be abandoned and for the government to instead re-visit some of the ‘real evidence-based policies’ – including minimum unit pricing – promised in the 2012 alcohol strategy (DDN, April 2012, page 4).

‘This report reveals the full extent of the failures of the responsibility deal to address alcohol harm,’ said IAS director Katherine Brown. ‘Perhaps more worryingly, it indicates the deal may have delayed evidence-based actions that would save lives and cut crime, such as minimum pricing. To call this a “public health responsibility deal” for alcohol is laughable, as almost every independent public health body has boycotted it.

‘With no support from the health community, and no evidence of effectiveness, it would be absurd for this government to continue with such a farcical initiative,’ she continued. ‘With alcohol costing our society £21bn each year, we can’t afford to keep prioritising the needs of big business over public health.’

Dead on arrival? Evaluating the public health responsibility deal for alcohol at www.ias.org.uk

Zero tolerance, zero cure

Chris FordMikhail Golichenko

Russian drug policies are fuelling the escalating HIV epidemic, says Chris Ford with input from Mikhail Golichenko

Last week I asked Viktor how he was, as his health seemed to be deteriorating. He relapsed again despite a desperate attempt to undergo drug treatment at Russia’s most renowned drug treatment clinic, the National Research Center for Drug Dependence. He had started using ‘khanka’, which contains opium, aged 16 years, and then tried a number of other drugs but he always went back to injecting opioids. For the next few years he was in and out of prison, and then in about 2004 he found out that he was HIV and HCV positive. Prison was followed by several attempts at detoxification, as this was the only drug treatment available, but each time he relapsed.

Last October the Russian government’s health committee held a meeting to discuss the rapidly growing HIV epidemic. The minister of health said that, at the current pace, the epidemic would grow 250 per cent by 2020 and any control would be lost completely – and suggested that HIV treatment coverage should be significantly expanded to include more people from vulnerable populations, including people who use drugs.

Authorities in Russia are aware that sharing contaminated injecting equipment by people who inject drugs remains the main driver of the epidemic (more than 57 per cent of new cases in 2014). Despite this, Russian officials continue with their dogmatic approach to harm reduction and in particular OST. Ignoring the overwhelming scientific evidence, the UN recommendations, and numerous examples of countries which successfully use OST for HIV prevention and drug treatment, Russia maintains a criminal ban on OST.

In 2010-2013 three Russian people (applicants) who use drugs went to the European Court of Human Rights (ECHR) challenging the criminal ban. All applicants are people who inject drugs with very similar stories of many years of opioid use and all its consequences, including HIV, hepatitis C, TB, prosecution by police, and incarceration. In the ECHR the applicants claimed that by denying them access to OST the Russian authorities had violated their right to be free from inhuman or degrading treatment, the right to private life, and the right to be free from discrimination.

Arguing against the applicants in the ECHR, the Russian case was based on a number of myths and misinterpreted facts, such as methadone once being called Adolphine after Adolf Hitler, or that OST medications lead to mental dementia, liver failure, or increased risk of overdose in comparison to heroin use. Authorities also try to mobilise drug treatment doctors, patients and their parents against OST. In October 2015 the ECHR received a 4,000 page submission from the Russian Government with signatures of several thousand people against OST, including doctors, patients, and their parents.

In addition each applicant suffered different persecutions: one applicant was arrested and interrogated about her OST application, another applicant suffered harassment by the authorities against a civil society organisation which provided support for him, and yet another applicant was fired from a government oriented drug treatment organisation for his position in favour of OST.

The legal battle in the ECHR is an example of how poor understanding of human rights by law enforcement and health authorities prevent science-based and cost-effective HIV prevention. The Russian Government argues that the legal ban on OST is to promote the right to health; the legal ban is mandatory for all, so there is no discrimination of any kind. The arguments that the Russian Government present to the European Court of Human Rights (ECHR) are based on the notion that the low level of retention in abstinence-based treatment, which is the only method of treatment available in Russia, has nothing to do with low effectiveness of this method of treatment. The Russian Government insists that the main reason why people who use drugs return to drug use after drug treatment is their low motivation to stay abstinent.

According to the government, the introduction of OST will further demotivate people who use drugs from abstinence. Taking this one step further, the authorities insist that the awful health and legal risks people who use drugs face should scare and ‘motivate’ them into abstinence – this in spite of there being no scientific evidence to support such an argument. Further, from a human rights perspective, such logic is discriminatory as the authorities ignore the vulnerability of people who use drugs to the adverse health consequences of illicit drugs and its associated life style, or in some cases use this vulnerability as part of the official policy of zero tolerance to drug use.

Also argued is that OST medications could be diverted to the illicit market and that OST medications can be misused and can cause death from overdose. This ignores evidence that inexpensive safety measures as well as health workers’ training can effectively minimise such risks, making the legal ban on OST completely disproportionate and unnecessary.

The ECHR hearings will take place sometime in 2016. Meanwhile, due to the government’s stubborn resistance to OST, thousands of people who inject drugs contract HIV every year. The current denial of access to OST in Russia is not unlike the denial of access to ARVT in South Africa at one time where myths and the ignoring of clear evidence led to millions of unnecessary deaths.

Mikhail Golichenko is at the Canadian HIV/AIDS Legal Network; Chris Ford is at International Doctors for Healthier Drug Policies (IDHDP)

 

Leaner and keener

Paul HayesIn a climate of austerity the new drug strategy must grow from our successes, says Paul Hayes on behalf of Collective Voice

Next month the government will begin its formal consultation to inform the drug strategy due in March. So how far has the 2010 strategy delivered its aspirations, and what insights have the last five years given us to help shape drug recovery for the rest of this parliament?

In the 2010 strategy the home secretary set out an ambition to ‘reduce demand, restrict supply, and support and achieve recovery’. The prime minister’s view at the end of 2012 was that this had been achieved: ‘We have a policy which actually is working in Britain,’ he said. ‘Drug use is coming down, the emphasis on treatment is absolutely right and we need to continue with this to make sure we can really make a difference.’

Despite the day-to-day challenges of delivery and the uncertainty of future funding following the spending review, we should not lose sight of the big picture – what the PM said was right in 2012, and remains right now. The policy is broadly achieving its aims and has been built on three pillars: a powerful positive narrative, endorse­ment of the clinical evidence, and a commitment to continue to invest.

The strategy successfully reframed the treatment system around recovery as an organising principle. The balance between ambition and evidence established a new consensus about best practice, steering clinicians to use opiate substitution therapy (OST) to provide a gateway to recovery for everyone who could take advantage of this opportunity. It also gave a secure place to build motivation and capacity to change for those not yet able to take the next step. This enabled the treatment system to promote recovery at the same time as continuing to deliver crime reduction and public health benefits – the bedrock of the success described by David Cameron, which it would be extremely unwise to unpick.

Crucially the government also backed the strategy with cash. Despite the extreme pressure on the public sector, funding committed to delivering the drug strategy was protected as part of NHS expenditure.

The 2010 strategy got the big calls right. It shaped a new ambition for the sector focused on the individual drug user, reached consensus on how to best achieve this together with wider societal benefits, and gave the resources to enable it to happen. However it also called for supporting action on jobs, houses, mental health, and a range of other crucial interventions which have not been delivered. The task for the 2016 version is to continue to deliver evidence-based, recovery-focused interventions, but to also overcome the strategy’s failures in the following areas (see opposite for details):

  • Drug-related deaths
  • Jobs and houses
  • Integrating prison and community
  • Mental health
  • ‘Locally led, locally owned’

Knitting all of this together would be health and wellbeing boards, which would integrate the local authority’s concerns with the Clinical Commissioning Groups’ (CCGs) continuing responsibility for drug users’ physical and mental health, and police and crime commissioners’ interest in the crime reduction yield from treatment. With some notable local exceptions, very few people would argue that the system is working on a national level. Health and wellbeing boards are understandably focused on social care as their overriding priority. Drug users are not a priority for either LAs or CCGs, and the decline in acquisitive crime which access to drug treatment has helped bring about has eroded the police’s role as local champions of treatment.

Commitment to drug treatment varies among directors of public health who lead on this for local authorities. Public Health England (PHE) has disinvested from its local presence, limiting not only its ability to promote and share best practice, but also the local intelligence it previously provided which enabled Home Office and Department of Health to understand what was really happening on the ground.

From 2018, local control of public health will be further strengthened as the public health grant is replaced by direct local authority responsibility for funding from business rates receipts. Unlike in 2010, drug and alcohol treatment is no longer part of the protected NHS spend but will have to compete for resources in the much harsher local government environment.

Continuing to deliver what has worked and overcoming the deficits will become increasingly challenging over the next four years, as the cumulative 20 per cent real terms reduction in the public health grant, announced in the spending review, removes the stability of investment that underpinned the 2010 strategy. Investment in drug treatment increased threefold between 2001 and 2008, since when it has been broadly flat with a slight decline since 2010, and a significant shift of existing resources from drugs towards alcohol since 2013.

There will always be scope for more efficient use of resources, and the best commissioners are working with providers to use innovation and integration to sustain or even improve outcomes. However too often the response is mechanistic recommissioning resulting in wasteful churn, or to demand reductions in contract price only deliverable through reductions in the quality of delivery. The sector needs to collectively and realistically assess what can be delivered, and the new drug strategy provides a timely opportunity to match ambition with resource.

The ideal 2016 strategy would look very like its predecessor – the key difference being to identify how to deliver the joined-up services everyone has known we need for at least 30 years. Key to this will be how best to champion an agenda that is not a natural priority for most of the individuals and institutions responsible for its funding and delivery. Collective Voice will work closely with government to identify workable solutions to this long-standing problem on behalf of all providers and in the interests of service users, their families and their communities.

Paul Hayes leads the Collective Voice project, a group of third sector treatment providers including Addaction, Blenheim, Cranstoun, CRI, Lifeline Project, Phoenix Futures, Swanswell and Turning Point

Tread softly

Public Health Nurses

How can we tackle child safeguarding without risking disengagement? DDN hears a cautionary perspective from public health nurses.

This focus on child protection is a good thing – but there are real consequences of focusing on it too much,’ said Karen Hammond of the Centre for Alcohol and Drug Studies, speaking at the recent HIT Hot Topics conference in Liverpool.

Hammond gave insight into the changing role of public health nurses in relation to mothers who used drugs – and described a very fragile relationship. Having access to families had been seen as ‘an opportunity for surveillance’, with nurses expected to take on an additional social work role, reporting on cases that they felt were high risk.

The effect of this could be to breed an ‘atmosphere of fear’ and ‘erode an already fragile trust’, denying these women a valuable source of support.

One-to-one interviews with public health nurses who worked with this group of women revealed problems with engagement: women were tending to withdraw from contact with nurses, for fear of having their children removed.

This failure to keep appointments was being blamed on their engagement with drugs and the notion of their ‘chaotic lives’, rather than ‘the cycle of fear and mistrust that had been created’.

The consistent issue to be highlighted was lack of training; many of the nurses had only had child protection as a training route to deal with these issues and thought they only needed to know about the names of drugs. This gave them perceptions such as: ‘addiction results in a loss of control and affects the ability to parent properly’; and ‘recovery is equated with abstinence’ – so any continued use signalled danger to them.

Hammond relayed some typical comments from the interviews with nurses: ‘The drug use takes over – that’s all they think about,’ and ‘They want to stop it but they can’t – the pull is just too strong.’ Children were also still deemed to be at risk when they were not actually present during drug-taking, and had been left with family members. ‘Nurses still thought [the mothers] wouldn’t manage their intoxication and it would end in chaos,’ she said.

‘Overall it was quite shocking – the belief that drug use makes you a bad mother,’ said Hammond. ‘We need to not only teach parents about risks, but also be able to facilitate some critical self-reflection that’s lacking at the moment.

‘Professional practice should reflect the evid­ence base, not political or moral frame­works,’ she said. ‘What we really need is to dismantle prohibition – but in the meantime we need to recognise that the way we’re dealing with it makes it worse.’

During the question time at the end of this session, a woman from Belfast commented: ‘I asked for help and my children were taken off me. You’re damned if you do ask for help and damned if you don’t.’

More from Hit Hot Topics in our next issue.

Safeguarding conference 2015 – playing safe

adfam conferenceAre we doing enough to protect children from their parents’ drug and alcohol use? At a recent safeguarding conference there was plenty of cause for concern, as DDN reports.

‘Graham Greene said “There is always one moment in childhood when the door opens and lets the future in.” We are responsible for opening that door,’ Joy Barlow told the Adfam/DDN Everybody’s business safeguarding conference, sharing her vision that we should refocus on the rights of the child.

The event brought together professionals with an interest in this sensitive issue and did not shy away from the challenging questions. Why were we missing signs that children were at risk? Were we aware that methadone soothing took place? How could we work more effectively with fewer resources? Why were we scared of even talking about this issue?

‘This is one of the most difficult and fraught areas of practice,’ said Barlow, who was formerly head of STRADA (Scottish Training on Drugs and Alcohol). ‘We need to incorporate respectful uncertainty,’ she said, quoting Dr Marion Brandon’s research from serious case reviews. ‘We need to demonstrate empathy and acceptance, but balance it with a healthy dose of scepticism… if the truth is not always presented to us, we have to ask why.’

Tackling safeguarding needed a fundamental shift in thinking, according to many of the day’s speakers and workshop contributors. Nic Adamson, CRI director, said drug and alcohol workers ‘often used to see it as their job to rock up and defend the client.’ But this area required a different way of working: ‘We need to learn to challenge clients’ behaviour – really challenge it,’ she said.

‘It’s a Pandora’s Box – there’s a fear in what we do,’ said one delegate, and this theme kept resurfacing, in relation to safeguarding, methadone, and the delicate issue of challenging clients and asking them difficult questions.

‘There are around 400 adult deaths involving methadone a year. Say this in the wrong room and you can be intellectually decapitated,’ said Martin Smith of Derbyshire Safeguarding Team, who brought the risks to children into sharp focus.

‘Hair testing has shown that methadone soothing is more common than we like to acknowledge,’ he said. Examples from his caseload included a child death which the mother had said was accidental, but tests had shown the child had been routinely given methadone: ‘A methadone storage box had been in place, she attended appointments, her engagement was good, there was a supportive grandmother – she gave the picture that all was OK.’ In another case, ‘a woman let a toddler ingest enough methadone to kill an adult’.

‘We lack honesty and courage as a sector – let’s not shy away from difficult challenges,’ he said. ‘It’s really hard to hear the bar is so low in certain areas… we’ve all got work to do.’

 

Pete Burkinshaw

Austerity is ‘the spoiler’ that leads to ‘the deadening hand of conflicting priorities’, Pete Burkinshaw PHE

 

 

 

 

 

Rachael Evans, policy and research officer at Adfam, brought evidence from case reviews that the charity had examined to produce the new report, Medications in drug treatment: tackling the risks to children – one year on. The main findings confirmed that there was insufficient appreciation of the dangers of OST by parents and professionals, and critical issues around safe storage. Practitioners were struggling to accept the idea of intentional administration of OST and felt that having these conversations might risk disengagement.

‘We’re so busy we forget to ask the right questions,’ commented Sue Smith, CRI’s national safeguarding lead. ‘But we need to challenge… it’s our role.’

‘I was bemused and shocked that my staff used to struggle around asking about safeguarding,’ said Birmingham commissioning manager, Max Vaughan. But, he added, ‘the combination of policing and being supportive can be really difficult.’ It was about confidence, suggested one delegate, adding ‘It shocks me that other agencies say “how do we ask those questions?” You just do. You have to.’

So apart from asking the right questions – about drug and alcohol use, drug storage, and making sure that risks to children were minimised – what were the key areas for improvement? Better engagement between all of the professional partners involved with the family came high on the list.

In Birmingham, the safeguarding structure involved team leaders, who had been fully trained in safeguarding , providing real-time updates to social workers, explained Micky Browne, CRI’s safeguarding lead. The Multi-Agency Safeguarding Hub (MASH) not only improved collaborative practice, but it also reduced inappropriate referrals, he said. ‘The better agencies work together, the more efficiency will develop in the long term.’

 

Joy Barlow, Sue Smith, Martinn Smith, Carole Sharma and Judith Yates

 

 

‘This is one of the most difficult and fraught areas of practice.’ Joy Barlow (below left), pictured with (clockwise) Sue Smith, Max Vaughan, Martin Smith, Carole Sharma and Judith Yates.

 

DS Steve Rudd, of Birmingham police, added: ‘When we sit round the Mash table now, we look a what’s happening – do police actually need to run off and lock mum and dad up? In multi-agency working we all come from a different angle. We’ve developed an under­standing of where we’re all coming from and issues are very quickly resolved.’

Exchanging data that was easy to comprehend was key to creating multi-agency risk assessments, said Sue Smith. Joy Barlow believed that we needed to overturn our culture of ‘educating in silos’, bringing drug and alcohol content to social work courses. ‘You’ve got to get people together in terms of learning and development,’ she said.

The Federation of Drug and Alcohol Professionals (FDAP) were working with Adfam to develop standards and identify competencies that people working with families should all have, said FDAP’s chief executive, Carole Sharma, who added: ‘This sector has been guilty of generating mystique around ourselves. We need to undo this.’

Dr Judith Yates was hopeful that Adfam’s new report would provide focus and remind commissioners of their power to make a difference.

‘I remember the Hidden Harm report landing on my desk and it’s stayed with me,’ she said. ‘Four years ago health visitors hadn’t had training on alcohol. I hope Adfam’s report will encourage people, including pharmacists, to talk to each other.’

Inevitably the question of diminishing resources came up throughout the day, and PHE’s Pete Burkinshaw describ­ed austerity as ‘the spoiler’ that led to ‘the deadening hand of conflicting priorities’. But Martin Smith urged delegates to remember that ‘profit should never come before the needs of children’.

‘We’ve got to have courage and honesty – and we’ve got to find evidence to back up what we’re trying to change,’ he said.

Among the challenging questions fired at the panel during the final session was the issue of whether child­ren should be trained and support­ed to administer naloxone to their parent in the event of an overdose. Should they be given that responsibility?

While Dr Judith Yates was among campaigners who had welcomed the recent extension of naloxone prescrib­ing, she was worried about ‘children having to parent their parent’: ‘It depends on the age of the child,’ she said. ‘There’s something not right about a six-year-old being entrusted to save a life.’

Martin Smith said the level of responsibility was too high, while Max Vaughan agreed ‘it doesn’t feel safe or right’. Sue Smith said that it shouldn’t be entrusted to a child ‘at this stage’. But several delegates threw back a challenge of double standards, referring to the ‘stigma of this client group’.

Vivian Evans

‘Workers in this field have passion and commitment, it’s harder than rocket science.Vivienne Evans, Adfam.

 

 

 

 

 

‘Many children are left to manage chaotic drug use who haven’t had proper support,’ said one. ‘Children, whether we like it or not, are managing their parents’ drug use. We’re guilty of double standards.’

At the beginning of the day, Joy Barlow had said: ‘I’m elated at what we’ve achieved and also severely disappointed at what we’ve achieved’ in this area of practice. Adfam’s chief executive, Vivienne Evans, finished on an optimistic note by saying that workers in this field had passion and commitment, which was ‘harder than rocket science’.

‘This is hugely complex and difficult work,’ she said. ‘We need to have that optimism that we can give children the best start.’

 

Ian Day

 

 

 

 

 

‘I was spotted, supported and encouraged,’ Ian Day.

 

 

 

In an emotional speech to the main conference, Ian Day looked back to 12 years ago when he was ‘deeply entrenched in addiction’. When his partner became pregnant he made a decision to be ‘a great dad’ – but nine months later he was in prison. ‘We slipped through the social services net,’ he said. ‘They had to be the enemy. But we were difficult people to work with.’

With his daughter taken into care he had spells of homelessness before being introduced to treatment service by an old friend, who was in treatment now herself and ‘looked good’. This is where ‘interventions came into play… it was a small window of opportunity to help a person. I was spotted, supported and encouraged’.

Six months out of treatment, he approached social services to try to win custody of his daughter who had been taken into foster care. He was ‘not, on paper, the person you’d give custody of a child to’ – ‘at that time the reaction was “you’re male”, I had nowhere to live and I hadn’t seen my five-year-old for three years. So I had to prove I could be that person.’

Securing a flat took two years, during which time he was tested continually by the agencies involved.

‘I had to see my daughter in a room with a person taking notes – I was very nervous,’ he said. ‘I got enrolled on courses and at the time it felt very demeaning – they asked very obvious questions. It was very frustrating, but looking back it was the right thing because of my previous history.’

With ‘all of the agencies speaking to each other throughout’ he had his day in court and won custody. Now settled with his daughter and current partner of six years, he says he is grateful for the ‘safe environment’ created by agencies working in partnership, which led him to an outcome he never dreamed possible.

A grim picture

Adfam’s new report shows children are still dying after ingesting medications used to treat drug addiction. Its author Rachael Evans, Adfam’s policy and research officer, shares findings

Adfam has particularly focused on safeguarding over the past couple of years. Publishing our new report Medications in drug treatment: tackling the risks to children – one year on, our research revealed that far more children than previously thought are dying and being hospitalised after ingesting medications prescribed to treat their parents’ drug addiction.

 

Rachael Evans

 

 

 

 

‘Specialist workers and midwives help a service maintain a whole-family focus.’ Rachael Evans, Adfam

 

 

In the ten years to 2013, at least 110 children and teenagers aged 18 and under in the UK died from the toxic effects of OST medications. In the same time, at least 328 children in England were hospitalised and diagnosed with methadone poisoning. Of the 73 deaths in England and Wales, only seven resulted in serious case reviews (SCRs).

Since Adfam first reported on this tragic phenomenon in 2014, these cases have continued to happen, with at least three new SCRs in the last year. While many children will have consumed the medications accidentally, some were given them by their parents in a misguided attempt to help soothe or send them to sleep. The statistics also show the majority of fatal poisonings involve older, rather than younger children – but little is known about how or why these incidents occur.

OST is proven to reduce dependence on street heroin, and by doing so it saves lives, improves health and wellbeing and cuts crime. The rightful place of these medications in addiction treatment is not at issue, but it’s imperative that the risks they pose to children are better addressed and future incidents prevented.

Our report makes a number of recommendations to help do this, starting with the need for all incidents involving a child’s ingestion of these medications to be fully investigated and recorded – and analysed centrally by government, with the learning shared with local services. The wide range of professionals who come into contact with parents and carers prescribed OST medications must all be trained about their potential harm to children, and services must work together and share information more effectively to minimise risk. Parents must also be educated about the potentially fatal risk posed by OST medications, and given a secure box to store them.

Vivienne Evans, Adfam’s chief executive, said: ‘The lessons from previous tragic cases have not been heeded, and a year after we called attention to the issue, children are still dying. The vast majority of parents prescribed these medications will use them safely and appropriately – but the number of children now identified as having been harmed lends the issue even greater urgency. Systemic and cultural failure means services are still not working closely enough to safeguard vulnerable children.’

Our research, along with the training we have delivered to local authorities, has identified some areas of good practice. One drug treatment service has appointed two specialist family workers to work with pregnant service users and families. Specialist workers and midwives can help a service maintain a whole-family focus, and this model was praised by SCR panels.

Another promising model is the development of inter-agency joint protocols between drug services and health visiting teams, so that information is shared and joint home visits can be conducted. More information and examples of good practice can be found throughout the report.

AdfamBy the end of 2015, Adfam will have trained 19 local councils to reduce the risks to children posed by these medications, and we hope to continue this crucial work in 2016.

 

December 2015

IDDN Dec 2015n this month’s issue of DDN…

What’s in store?

Continuing to deliver what has worked and overcoming the deficits will become increasingly challenging over the next four years, as the cumulative 20 per cent real terms reduction in the public health grant, announced in the spending review, removes the stability of investment that underpinned 2010,’ says Paul Hayes, speaking on behalf of the Collective Voice project, in our new issue DDN.

Not only does the sector need to ‘collectively and realistically assess what can be delivered’; it needs to work out ‘how best to champion an agenda that is not a natural priority for most of the individuals and institutions responsible for its funding and delivery,’ he says.

Send us your views!

PDF Version / Virtual Magazine

Cold caller

Chris RobinA craving is the salesperson we can choose to ignore, says Chris Robin

It’s a fact that a craving has to strike before a person uses drugs or alcohol, and that’s why they can be terrifying for service users. A common technique in dealing with cravings is to distract the individual from their desire to ‘use’. Yet, if someone avoids something the result is often a sense of fear, and from fear comes powerlessness. The substance user must be able to face their fear!

A craving is like a salesperson. Its purpose is to sell the thought of using to the customer and make it look attractive. It sells the idea of pleasure and euphoria.

It doesn’t talk about comedowns, or any other side effects, as that information would get in the way of the pleasure. The salesperson reminds the customer that if they use the product, it will change the way they view the world immediately, and that they will be stress and problem free.

In the break-up of a relationship, even if the decision to part was the right one, the parties will continue to yearn for one another, and the loss they experience will be extreme. This could be said of the service user’s relationship with substances, as they will miss their drug of choice and experience longing and desire as well as grief for the loss. Cravings – the salesperson – will fully understand this and will know how to target those feelings, either blatantly or silently, to keep selling the product.

When we help service users to look at their relationship with a drug, it is important to acknowledge the yearning they may experience and the grieving process they are going through. Rather than distract them from these feelings, give them permission to be honest about the craving, so they can be aware of the sales pitch that is being used on them. This recognition will then inform the craving that it has been exposed, so it will have to become less blatant, more subtle, more silent, more devious, to make the sale. Again the worker’s job is to help the service user to investigate these devious cravings so they can understand their sophistication.

Equipped with this information, the service user then has the tools to communicate with their cravings, stand up to them and say: ‘I see you, I know your agenda, and I am no longer afraid of you!’

Chris Robin offers treatment and training at Janus Solutions, www.janussolutions.co.uk

First impressions

Shahroo IzadiThe pressure to collect data from new clients should not replace essential rapport, says Shahroo Izadi

Emerging Horizons’ facilitators often begin training by asking delegates to describe why they do the job they do. Answers rarely deviate from themes such as being naturally engaging, an ability to build rapport, strengths in communicating empathy and a genuine desire to help.

These qualities are at the very heart of conducting an effective assessment, one that begins the non-judgemental process of supporting individuals to establish values, uncover strengths and build upon them.

Frequently, however, staff report that the rushed box ticking, contract signing and form filling required at first point of contact has become professionally debilitating. It seems widely accepted that therapeutic intervention begins during the second appointment (provided the client has come back).

Despite positive improvements across the substance misuse sector, it seemingly remains widely acknowledged that traditional health and social care assessments are too focused on deficits and inadequacies, with some practitioners expressing concerns that their deficit-based assessment procedures may actually disempower and intimidate those who have found the courage to seek their help. Given the space to reflect, delegates often also realise how commonplace it has become for this crucial first meeting to be facilitated in a room ‘decorated’ exclusively in posters threatening certain death from overdose, HIV and hepatitis, often precariously tacked next to greyscale warnings of the latest bad batch of heroin in local circulation.

Workers often report feeling pressured to hurriedly collect meaningful and reliable data on highly personal experiences such as sex working, abuse and illegal behaviour. Some staff have admitted during training that it was not until they had built rapport with their clients that they realised how much of the information collected at point of assessment was inaccurate.

Assessment protocols need to be systematically reviewed, updated and facilitated in a welcoming environment that models recovery. The paperwork should be designed as a tool to assist practitioners in collaborating with their clients on the development of a strength-based, person-centred recovery plan. For this to happen, even essential data capturing needs to be concise, accessible and client-led, as well as designed to focus on establishing recovery capital in areas such as relationships, social pursuits and life purpose.

Shahroo Izadi is development manager at Emerging Horizons, www.emerginghorizons.org

Bucking the trend

Josie Smith Chris EmmersonUnlike in England, drug deaths in Wales have been falling since 2010 – a result that can be traced to Welsh public health policy and harm reduction practice, say Josie Smith and Chris Emmerson 

 

As previously reported in DDN (October, page 4), according to data from the Office for National Statistics (ONS), a total of 2,248 deaths from drug misuse were registered in England and Wales in 2014 – a rise of 14.9 per cent on 2013.

Building on the near 20 per cent increase in drug misuse deaths from the previous year, a notable change in the pattern of drug deaths seemed to be emerging.

However, this paints an inaccurate picture. While drug misuse deaths in England have risen dramatically over the last two years, drug deaths in Wales have fallen year-on-year since 2010, with a 30 per cent decrease in the last five years to a total of 113 deaths – a rate of 3.90 per 100,000 population.

With drug misuse deaths in England now at their highest level over the 22 years for which the ONS publishes figures, the need for credible explanations for the rise became urgent.

One set of explanations has focused on changes to drugs and those who use them. The ONS, in the statistical bulletin accompanying the release of the 2014 figures, points to changes in the purity of street heroin (as reported by SOCA, the UK’s Serious Organised Crime Agency) as a possible influence on variations in drug deaths over recent years. Sustained rises in reported purity coincided with increases in deaths involving heroin/morphine in England. The ONS also suggests that, with increasing numbers of deaths among older drug users, the generation who began injecting in the 1980s and 1990s are aging and therefore at higher risk of dying from drug-related causes as other health problems take their toll.

However, the same ONS report provides another key piece of information that challenges the focus on changes to drugs and this demographic of drug users as key reasons for rising drug deaths. It comes on page 19: ‘…whilst drug-related deaths in England have now reached an all time high, those in Wales have fallen over the same period, down 16.3 per cent in 2014 to 113. Indeed, the rate of drug misuse deaths across the Welsh population, at 39 per million, is now less than England for the first time since 2004.’

With no reason to believe that either heroin markets or drug-using careers in Wales are substantially different to England, how can we explain the difference?

The second narrative to emerge following the release of the figures is that the difference is down to policy and philosophy. With health policy devolved within the UK, it is the Welsh Government that decides the priorities for substance misuse in Wales. In contrast to England, where – as reported in last month’s article on the National Needle Exchange Forum meeting (DDN, October, page 16) – many users, frontline staff and managers are finding reduced funding and support for well-evidenced harm reduction approaches in favour of abstinence based ‘recovery’ models, Wales has maintained focus and funding for harm reduction.

In response to the release of the 2014 figures, deputy minister for health Vaughan Gething said, ‘These figures represent lives lost to families and communities across Wales and while I welcome the news of a further decrease, any death attributable to drugs is one too many.

‘Tackling drug misuse is a complex issue, which the Welsh Government has been working hard to address. The fact that drug-related deaths are falling at such a rate in Wales is testament to the significant work, which we and our partners are undertaking.

‘We are investing almost £50m a year in programmes including a bilingual substance misuse helpline, a take-home naloxone programme which reverses opiate overdose and the WEDINOS harm reduction project which tests substances. These figures show that this money is delivering tangible benefits.’

Also commenting on the figures, Josie Smith said, ‘It is a testament to the National Substance Misuse Strategy in Wales, Working together to reduce harm, ongoing support for harm reduction services and a willingness to innovate new approaches to reduce risk, that have resulted in fewer drug deaths in Wales. Problematic drug use in Wales remains but the most severe of consequences, that of premature death, is declining through better engagement, appropriate and evidence-informed interventions and collaborative working.’

Josie Smith is head of substance misuse programme and Chris Emmerson is information analyst specialist at Public Health Wales

The state we’re in

Erin O'Mara

Forcing stable people off their heroin scripts and into chaos is evidence of a British drug treatment system in terminal decline, says Erin O’Mara

‘I feel like they are waiting for the last handful of us to die off and that will be the end of heroin prescribing in Britain, as we know it’, I said miserably.

Gary Sutton, Release’s head of drugs services, turned and looked at me seriously through his spectacles: ‘If we don’t try and do something now there will be no diamorphine prescribing left anywhere in the UK.’

Gary tapped away on the computer in front of me, putting the last few lines on a letter to yet another treatment service who had been forcibly extracting a long-term client off his diamorphine ampoules and onto an oral medication. It was proving to be a painful and destructive decision for the client, who was experiencing a new daily torment as his once stable life began to unravel around him.

The drug team and its helpline (known affectionately as ‘Narco’), all part of the UK charity Release, receives phone calls from people in drug treatment from all over the UK. By doing so it serves as the proverbial stethoscope clamped to the arrhythmic heart of our nation’s drug politik and bears witness to the fallout from Number 10 affecting the individual, on the street and in treatment. In other words, we witness the consequences of policy and treatment decisions, and try to support or advocate for the caller.

But as winter draws the shades on yet another year in the drugs field, we find we are bearing witness to a tragedy, one of small proportions but with huge implications. It involves the last vestiges of the British system of drug treatment, the ‘jewel in its crown’ – heroin prescribing – and the decline of the NHS, under assault from a mercilessly competitive tendering process and the crude procurement that is defining its replacement. Is that where we are really heading?

It may be true to say that to try to define the old ‘British system’ is to trap its wings under a microscope and allow for a possibly contentious dissection; the late ‘Bing’ Spear, formerly chief inspector of the Home Office drugs branch, might be first in line by reminding us that the implications of ‘“system” and “programme” suggests a coordination, order and an element of (state) planning and direction, all totally alien to the fundamental ethos of the British approach, which is to allow doctors to practise medicine with minimal bureaucratic interference’. His point being that the essence of the ‘British system’ was that it ‘allows the individual doctor total clinical freedom to decide how to treat an addict patient’.

John Strang and Michael Gossop, in their thoroughly researched double volume book Heroin Addiction and the British System, stated in the epilogue of volume two, that ‘amongst the (probably unintended) benefits of [this] approach may be the avoidance of the pursuit of extreme solutions and hence an ability to tolerate imperfection, alongside a greater freedom, and hence a particular capacity for evolution.’

The British ‘approach’ (as may arguably be a more appropriate phrase to use) had once allowed for a level of evolution; of experimentation and pharmaceutical flexibility; three characteristics that are glaringly missing from frontline drug treatment today. Although we have no room to discuss clinical guidance here, it is often the case that when presenting services with complex individual cases at Release, we are rebuffed by the response ‘it’s not in the guidelines’, ‘it’s not licensed’, or even, as if drug workers are loyal party backbenchers, ’it’s not government policy’!

Hindsight is a gift, and although many of us could while away the hours pontificating about just how and why it all went so publically wrong for our ‘unhindered prescribers’ back in the day (think Drs Petro, (Lady) Frankau, and a handful of others), that would be to miss the point. The reality is, once we pick up and examine the pieces of the last 100 years, there are shining areas of light in our British approach. Marked by both a simple humanity and a brilliant audacity, it permitted a private and dignified discussion between doctor and patient to find the drug that created the preconditions for the ‘patient’ (today the ‘client’) to find the necessary balance in life.

Are we really back to the days of having to ask to be treated as an individual? Policy is now interfering in treatment to such an extent that the formulation that the patient feels works best for them (physeptone tablets, heroin, morphine, oxycodone, DF118s etc) may no longer fit into today’s homogenous and fixated theme of methadone or buprenorphine, one part of a backwards step.

The days when heroin prescribing was defended as tenaciously as a doctor’s right to prescribe unhindered are almost gone. Fear and public ignorance have forced us to collapse any new diamorphine prescribing into a tight wad of supervision, medicalisation and regulation while prohibition, politics and the soundbite media have meant that we have been doomed to discuss this subject under the umbrella of ‘treating the most intractable, the most damaged, the treatment failures, the failures of treatment’.

Why must a treatment that has proven to be the optimum for so many people be left until people had been forced to suffer through a series of personal disasters and treatment failures? Did this narrative help to diminish the intervention?

The last few dozen people left on take home diamorphine prescriptions in the UK today seem to be stable, functioning, often working people who no longer have so much a ‘drug problem’ as a manageable drug dependence. This last group of diamorphine clients are remnants of the old system with, it appears, no new people taking their places once they leave. Today these are some of the very people who are now ringing the Release helpline to try to save their prescriptions altogether. They are frightened, most of them are in their fifties and had qualified for diamorphine many years ago because ‘nothing else worked’; what now are they to do?

Diamorphine prescribing has been ensconced in a political and clinical debate about the expense and fears of an imaginary tsunami of diversion. Yet what of today’s financial wastage? We have ways to deal with diversion, yet poor and frequent commissioning has a number of serious consequences, including a lack of continuity of care, a slide back to postcode variance and, not least, cost. An exercise to quantify the costs of tendering services more than ten years ago came up with a figure of £300,000 as the sum expended by all bidders and the commissioner, per tender – money that could be better spent, surely?

A few weeks ago the LSE put on a mini-symposium on diamorphine with a panel of international clinicians, academics and research experts. Everyone present agreed that prescribing diamorphine, albeit in a very controlled, supervised manner, had tremendous merit. Taking the idea from the success in Britain (eg Dr John Marks), today we see a method that has evolved across Europe; the Swiss, the Dutch, the Germans and the Danes, among others are all doing it – treating thousands of clients and with great results. So it was more than frustrating to hear that our own diamorphine clinical trials had been closed this year with no plans to restart them.

Diamorphine should not end up marginalised and discarded because a controversial new ‘system’ finds it far harder to tolerate than the patients who receive it do.

The benefit is proven. It’s not a choice between maintenance and abstinence. Addiction is not reductive to either/or and, as treatment is neither just a science nor an art, clinicians should not be restricted to methadone or subutex, or our clients subjected to a binary ‘take it or leave it’ choice in services.

Erin O’Mara is editor of Black Poppy mag­azine and is currently volunteering at Release

 

Medications in drug treatment: tackling the risks to children

Vivian EvansOST and children: lessons still ‘not heeded’, says Adfam

More children than previously thought are dying or being hospitalised after ingesting opioid substitution therapy (OST) medications, according to a new report from Adfam. The document is a follow-up to the charity’s hard-hitting Medications in drug treatment: tackling the risks to children report from last year, which found that the safeguarding of children was not being sufficiently prioritised (DDN, May 2014, page 4). The lessons from previous tragic cases have still not been learned, the charity says.

While the first report identified 23 incidents of ingestion and 17 child deaths in the decade to 2013, mortality and hospitalisation data uncovered since reveal a far more serious situation, with 110 children and teenagers under 18 dying as a result of ingesting OST medicines over that period and at least 328 diagnosed with methadone poisoning after being hospitalised. ‘The new statistics are shocking,’ says the document, stressing that they add ‘weight and urgency’ to the issue. There have also been at least three more serious case reviews since the publication of the last report, Adfam points out.

The charity wants to see all incidents of children ingesting OST medication ‘fully investigated and recorded’, with the information properly analysed and shared with local services. Although many incidences result from accidental ingestion, in some cases the medications are deliberately administered by parents ‘in a misguided attempt’ to help soothe or send children to sleep, it says. Adfam is calling for proper training for parents as well as for all professionals who come into contact with parents and carers prescribed OST drugs.

‘The lessons from previous tragic cases have not been heeded, and a year after we called attention to the issue, children are still dying,’ said Adfam chief executive Vivienne Evans. ‘The vast majority of parents prescribed these medications will use them safely and appropriately – but the number of children now identified as having been harmed lends the issue even greater urgency. Systemic and cultural failure means services are still not working closely enough to safeguard vulnerable children.’

Medications in drug treatment: tackling the risks to children – one year on at www.adfam.org.uk

Safeguarding in Treatment – feedback form

[contact-form-7 id=”12854″ title=”Safeguarding in Treatment – feedback”]

Treatment threatened by constant re-procurement, warns ACMD

Annette Dale PereraThe quality of treatment for heroin users is being threatened by diminishing funds and ‘disruptive re-procurement processes’, according to a new report from the Advisory Council on the Misuse of Drugs (ACMD).

Treatment quality now varies significantly across England, says the document, and is being further compromised by ‘frequent re-procurement and shrinking resources’. The report stresses that investment in drug treatment needs to be protected, as it is cost-effective and beneficial to society, and it calls for the implementation of a national quality improvement programme. It also wants to see more done to create a ‘culture of stability’ and reduce ‘churn’ in local systems.

The document, which also considers issues such as how to tackle low expectations of recovery, how to prioritise resources to achieve better social reintegration, and how to address misuse and diversion of OST medication, is the final of two ACMD reports into opioid substitution therapy commissioned by the Inter-Ministerial Group on Drugs. The first, published late last year, firmly rejected the idea of time limits on substitution treatment (DDN, December 2014, page 4).

‘Everyone with heroin dependency should have access to high-quality drug treatment,’ the document states, expressing concerns about lack of progress on helping people ‘achieve employability’. More effort is required to achieve this, it says, including vocational training, supported work placements and ‘targeted employment schemes’, including tackling stigma among employers.

However, a ‘significant number’ of heroin users new to treatment appear to be able to complete that treatment and not return, it stresses, particularly if they ‘stop using heroin within six months of starting OST’. Those who are stable and remain in OST for more than five years or more, meanwhile, should ‘be positively regarded as in “medication-assisted recovery”,’ which should ‘not hinder access to healthcare interventions, peer-led recovery interventions and social integration’. This group should not be discriminated against simply because they are in OST, the report warns.

‘Government has done well to achieve widespread recovery-orientated drug treatment for heroin users,’ said co-chair of the ACMD’s recovery committee Annette Dale-Perera. ‘Treatment protects against drug-related death, ill health, chaos caused by addiction, and crime and can help people turn their lives around. We need to act to improve, and not lose, this valuable asset to society.’

How can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users? at www.gov.uk

Local news from the substance misuse field

Addiction charity wins excellence awards

Phoenix Futures has been awarded two UK excellence awards for leadership and customer satisfaction by the British Quality Foundation (BQF).

BQF awardsThe awards recognise organisations that have demonstrated excellence in all areas of operation. To become a finalist, Phoenix had to be recommended by assessors who visited their services earlier this year, and former resident Lawrence Smith shared his personal story with the BQF panel as part of their entry.

Phoenix staff received their awards from businesswoman and star of The Apprentice Baroness Karren Brady CBE at a recent black-tie event.

‘The most incredible part of winning these two awards for leadership and customer satisfaction is that every single staff member and volunteer can feel proud that they helped contribute to Phoenix’s success,’ said chief executive Karen Biggs.

 

RoRLaunch event celebrates new recovery service

Reach Out Recovery (ROR), a drug and alcohol recovery service in Birmingham, has recently celebrated the opening of its new service.

The facility, which opened in March, offers an holistic approach and supports people within their own communities by offering life skills such as finding a job and rebuilding past relationships.

CRI’s executive director Mark Moody and director Nic Adamson opened the launch event, which was attended by staff, service users and representatives from local services and communities.

The event included presentations and workshops, highlighting the support being offered and sharing success stories from the service.

 

Forward LeedsDrug and alcohol advice offered to students

Staff from Forward Leeds have been educating university students about drugs and alcohol misuse at freshers’ events across the city.

Students had the chance to take part in activities such as ‘beer goggle darts’, while being given advice on understanding the effects of different drugs and alcohol and how to remain safe.

‘We’d like to get students thinking about the risk factors around drinking and drug taking. We want them to stay safe,’ said Jane Doyle, early intervention and prevention lead practitioner.

 

Programme for ex-servicemen receives funding

The Forces in Mind Trust (FiMT) has awarded a grant to Edinburgh-based charity Venture Trust to fund the Positive Futures project, which will support ex-servicemen and women across Scotland who are struggling to adapt to civilian life.

The programme will offer participants support in three stages – advice on employ­ment, personal development and referral to services where needed; a personal develop­ment programme and one-to-one and group support sessions; and ongoing support focused on internships, employment and peer mentoring to help individuals move forward with their lives.

 

Tea roomsRecovery house offers better access to support

A new recovery house has been opened in Staffordshire for those who have completed rehabilitation and want to return to their home area.

The centre will help people access support, short-term accommodation, and education and skills training, as well as engaging families in the recovery process. Langan’s tea rooms, a social enterprise, will also offer volunteering and employment opportunities.

The house was opened by Secretary of State Iain Duncan Smith and representatives from Burton Addiction Centre, Cannock Chase District Council and Staffordshire County Council.

 

News beginningsPeer mentors gain full-time employment  

Two ex service users have begun new careers as support workers after graduating from a peer-mentoring scheme in Doncaster.

Daniel Bowden and Joe Sheerin were both supported by Doncaster’s Drug and Alcohol Services during their recovery, and became volunteer peer mentors to help others on similar journeys. Both men went through a rigorous interview process for their new roles – Daniel at the Alcohol and Drug Service (ADS), and Joe at New Beginnings drug and alcohol rehabilitation centre.

‘By sharing their own experiences, peer mentors deliver vital support to people beginning their recovery journeys,’ said volunteer and mentor coordinator Lydia Rice. ‘They offer empathy and encouragement, and play a valuable role in motivating others.’

 

National news from the substance misuse field

BRIEF BRIEFING

‘Decisive’ coordinated action is needed to ensure a future for alcohol brief interventions, according to a report from the Alcohol Academy and Alcohol Research UK. Alcohol identification and brief advice (IBA) has proved difficult to implement effectively, says the document, with ongoing issues around primary care as the key setting and ‘understanding what brief intervention actually involves’. Alcohol brief intervention: where next for IBA? at alcoholresearchuk.org

 

SEIZURE STATS

The number of drug seizures in England and Wales fell by 14 per cent in 2014-15 to just over 167,000, according to figures from the Home Office. More than 124,000 of these were seizures of cannabis – down by 17 per cent on the previous year. Overall class A seizures were also down by 10 per cent, despite seizures of heroin increasing by more than 70 per cent. Seizures of drugs in England and Wales, 2014/15 at www.gov.uk

 

HELP IN SIGHT

The first guide to substance use and sight loss has been published by the Thomas Pocklington Trust, and includes key resources for professionals and best practice examples. ‘Our research found that both sight loss and substance abuse services are not adequately equipped to deal with these overlapping issues,’ said lead author Sarah Galvani. ‘Substance abuse can sometimes be used as a coping mechanism for sight loss, but the combination of both issues can create a complex challenge for support professionals.’ Substance use and sight loss at alcoholresearchuk.org

 

SAFEGUARDING ACTIONsafeguarding

More children than previously thought are dying or being hospitalised after ingesting opioid substitution therapy (OST) medications, according to a new report from Adfam. The charity says lessons from previous tragic cases have still not been learned and wants to see all incidents of children ingesting OST medication ‘fully investigated and recorded’, with the information properly analysed and shared with local services. Adfam is calling for proper training for parents as well as for all professionals who come into contact with parents and carers prescribed OST drugs.

Medications in drug treatment: tackling the risks to children – one year on at www.adfam.org.uk

See feature, page 12

 

HELPING CHILDREN TALK ABOUT PARENTS’ TREATMENT

Joanna ManningA new resource booklet has been produced by The Children’s Society to help young people affected by a parent or carer’s alcohol or drug treatment.

Help me understand aims to encourage ten to 14-year-olds to talk to support workers and has been designed to communicate simply and directly, including messages from others in the same situation.

‘While having a parent or carer in treatment can be a positive thing, it can also be very confusing and distressing,’ said Joanna Manning, national lead on substance misuse at The Children’s Society. ‘[This] will be a valuable tool for workers to use in helping children and young people to stay safe and to understand the importance of accepting and sharing their feelings.’

The booklet was launched at Adfam/DDN’s safeguarding conference Everybody’s business, held in Birmingham.

Available to download at www.starsnationalinitiative.org.uk

 

 

Comment from the substance misuse sector

Letters

Letters and comments

DDN welcomes your Letters Please email the editor, claire@cjwellings.com, or post them to DDN, CJ Wellings Ltd, 57 High Street, Ashford, Kent TN24 8SG. Letters may be edited for space or clarity.

No offence

Although we feel strongly about the subject of our letter (DDN, October, page 8), on reflection some of the language used was perhaps inappropriate and we apologise to those concerned. In particular we in no way wanted to offend Mr Marteau, who has worked tirelessly in this area for decades and helped to improve care for those with addiction problems.

Dr Chris Ford, Dr Clare Gerada, Dr Euan Lawson et al

Just to clarify

Dear Chris and all, I am grateful for your generous words. To clarify your letter’s point about France, the French treatment system as a whole now has 70 per cent of OST patients treated with buprenorphine, 30 per cent with methadone. The latest French drug-related deaths and OST data (OFDT, 2014) indicate that methadone was seven times more dangerous than buprenorphine in 2012.

If we are to retain methadone as first line, it is incumbent on us to demonstrate that methadone is several times more effective than buprenorphine at keeping the population alive. If it is not, and I have deep concern that this is the case, then we are in the realm of avoidable deaths.

Dave Marteau

Dangerous words

In a climate where those undergoing treatment with methadone are increasingly finding themselves on the end of daily supervised consumption, I found the letter ‘Marteau complex’ signed by Dr Chris Ford et al in last months DDN, which seemed to condone diversion, wholly unhelpful.

It may be OK stating this as a ‘what if?’ academic flight of fancy, but when you’re a service user facing an increasingly punitive drug treatment system, this kind of statement merely provides more ammunition for those voices against OST and methadone in particular.

Peter Simonson, London

Misleading stats?

I am writing to express my disappointment at the way in which the drug poisoning deaths in England and Wales were portrayed in your article (DDN, October, page 4).

The article as written suggests that drug poisoning deaths have risen in Wales as well as England. This is clearly not the case.

In 2014 there were 168 drug poisoning deaths in Wales, a decrease of 40 (19 per cent) compared with 2013, and the lowest since 2008.

Gareth Hewitt, head of substance misuse policy and finance, Welsh Government

DDN responds: Our news story does state in the third paragraph, ‘While England saw a 17 per cent increase in its drug misuse mortality rate… Wales saw its proportion drop by 16 per cent to 39.0 per million, the lowest figure for almost a decade.’ The reference to England and Wales registering the highest number of deaths reflects the ONS reporting region.

Drug and alcohol in the news

Media savvyMedia savvy

The news and views from the national media

If the Lib Dems have any function now, it’s on issues such as drug decriminalisation, child detention, prison reform, surveillance: civil liberties. With Jeremy Corbyn’s Labour we have a puritanical left where personal freedom is less important than some holier-than-thou posturing. The hair shirt opposite of Theresa May’s nastiness… We could do with a party that believes in personal freedom. It’s a shame it’s led by the semi-vicarish Tim Farron, but if they can puncture some of the hypocrisy on drug laws, good for them. This is hardly radical, just sensible.

Suzanne Moore, Guardian, 12 October

Had the e-cigarette been invented and patented by a pharmaceutical company and promoted by the government, it would have failed. Big Pharma would have called the device Niquo-Stop453, made it from plastic, packaged it in boring green and white and sold it in chemists’ shops. No bureaucrat or corporate lackey would have thought, ‘What if we call it Unicorn Puke and sell it like a high-end electrical product?’ To smokers, switching to Niquo-Stop453 would have felt like a sad compromise: like being treated for a disease. Switching to Unicorn Puke feels like a choice.

Rory Sutherland, Spectator, 24 October

Whatever alcohol companies do to fight back against the declining popularity of booze, deep changes in British culture have made booze less attractive. Forget the horrific tales of drunken escapades from Magaluf to the Bullingdon Club. The real story is of the strange death of boozy Britain.

Tim Wigmore, New Statesman, 9 October

There is a contradiction at the heart of the policy agenda, where a rhetorical commitment to patient choice turns out to be fatally compromised by a paternalism that the health service claims to have abandoned. Patronising people and protecting them from themselves just won’t wash anymore. If we choose to smoke or vape, or drink or eat too much, that should be up to us.

Dave Clements, Guardian, 1 October

A balanced assessment of the evidence, rather than the ideology, surely is the best guide to policy. For my own part, a softening of the legislation on drug use (coupled, of course, with access to medical treatment), combined with a hardening of social attitudes against it appears the most fruitful way forward.

Hamish McRae, Independent, 21 October

 

Supporting vulnerable women

Nicky GoulderTake a bow

Nicky Goulder talks about how an acting workshop is supporting vulnerable women in east London

For over five years, arts charity Create has helped vulnerable women in east London make steps to reshape their lives through the creative arts. In collaboration with international law firm Reed Smith LLP and U-Turn Women’s Project, Create’s workshops reach women of all ages who have been trapped in cycles of prostitution, drug addiction, physical abuse and homelessness from an early age.

Since July, the women have been working with Create’s professional actor and playwright James Baldwin, collaborating to write original stories and outline plots that feature a problem, a journey, an obstacle and a solution, echoing the challenges that they have experienced themselves. This has allowed them to share their experiences and expand their support networks to include other vulnerable women within their community.

Every year, women are forced into prostitution through a combination of homelessness, drug use, poverty and domestic violence, which accounted for 30 per cent of all violent crime in Tower Hamlets in 2009-10. Create uses the creative arts to inspire self-confidence in vulnerable women who attend the U-Turn centre, encouraging them to develop trust, friendships, communication skills and pride through collaborative activities. These skills and qualities can then be used in day-to-day life, helping the women reclaim control over their futures.

U TurnMargaret has a history of drug use but is currently in recovery and has been abstinent for seven years. She attended the centre initially for general support with benefits and some ongoing confidence issues, but is more confident and independent now. ‘You learn so much,’ she says of the workshops. ‘Communicating with other people that you really don’t know and things like that. A lot of my confidence went and I have just started to get my confidence back since coming here. It had been gone for years and years.’

Nicky Goulder is CEO of Create

https://www.facebook.com/create.transforming.lives

Addiction and recovery in East London

Graham MarshallThe times they are a changin’

As Spitalfields Crypt Trust (SCT) celebrates 50 years of helping people in recovery, CEO Graham Marshall looks back at the changing landscape of addiction and recovery in East London

When I was young I experimented with drugs and got into trouble. After spending a year in rehab, I started volunteering for SCT in the late ‘70s and have stayed ever since. My first job mainly involved giving sandwiches and clothing to homeless callers at the crypt, and talking to them. It was run from Christ Church Spitalfields, and we provided a supportive environment and an increasingly challenging programme for about 18 men with alcohol problems who came in straight from the streets or the local detox in Whitechapel.

The crypt was once a ‘dry house’ for homeless alcoholic men. In the early days, these were the most hardcore drinkers around. Cider, wine, methylated and surgical spirits were the most common drinks then, and in that order. This was back when Spitalfields was a big fruit and veg market, with countless places or derelict building sites where people could sleep, called ‘derries’ and ‘skippers.’

We moved our residential programme to Shoreditch where we now support 16 men, recovering from their addiction in a much more intense way than we ever could back when I started.

Back in the days of the crypt, we realised that just keeping the men warm and dry was not enough and many of them had very basic living skills. They might know how to get by on the streets, but they did not know how to ‘do life’ – find a job, a home and cook a meal for themselves. There was no aftercare. They got sober, but didn’t have a recovery programme. So we set one up, drawing heavily on the 12-step programme.

We run a personal development and training centre, and three social enterprises where individuals can learn the skills of working with people and gain experience that will give them a chance of finding a job. Much of our work is supported by our own fundraising efforts and charity shops.

I still love my work – I see positive change. It’s about people coming off dependency and recovering their sobriety, and learning to love life, themselves and others.

Graham Marshall is CEO of Spitalfields Crypt Trust. www.sct.org.uk

Literacy and drug treatment

Richard HomerThe writing’s on the wall

Literacy issues can be a barrier to participant engagement and successful outcomes in substance misuse treatment programmes. Richard Homer explores the reasons why

There’s a host of common challenges when delivering drug treatment programmes. One of the biggest is how to ensure participants understand and retain the content presented to them.

There are five persistent limitations that prevent individuals from accessing the right treatment for their level of understanding: many programmes place emphasis on written work, but classroom environments can be difficult for those with negative experiences of school and topics and terminology can confuse those who struggle to grasp the extent of their substance misuse. People with English as an additional language, meanwhile, are rarely provided for, and basic training for facilitators is sometimes missing.

With the right approach, these are preventable – even when coupled with additional factors such as poor concentration (often due to detox) and restrictive attendance criteria. However, another key limitation in many cases is the comprehension of a programme’s content. Many programmes do not allow for personal academic ability, mental health, language or cultural differences. As a result, programme content can be confusing due to the diverse way in which teaching can be delivered and learned.

Substance misuse programmes are often ‘word-heavy’, and require participants to ex­press themselves in a universal way. Govern­ment data shows that a high percent­age of individuals accessing treatment have low literacy levels and learning disabilities. Many have jumped hurdles to start a treatment programme, only to discover the material requires a level of focus, comprehen­sion or language beyond their ability

So why does this problem need to be tackled? While low literacy doesn’t necessarily lead to drug and alcohol issues, it is imperative that we address substance misuse in a way that is accessible to all abilities and learning styles. Ignoring this will result in certain groups of people falling through the cracks of the treatment system and never reaching their potential for recovery.

Richard Homer is managing director of Vivid Training www.vividtraining.co.uk

Service user involvement

The Worm coverThe worm has turned

The Worm, a new service user-led magazine recently launched in Haringey, is tackling stigma and promoting a positive image of people in recovery

Back in July 2014, a group of individuals accessing treatment at Haringey’s alcohol treatment service decided to get together and use their personal experiences to do something to address the stigma faced by those in recovery.

They settled on the idea of a magazine to promote understanding about recovery, and, slowly, a team began to form, encouraged to use the skills they already possessed. With the backing of the service staff, founding member Jac Geraghty applied for – and ultimately received – funding for the project.

The Worm was born, and after much hard work, an event – which included music, poetry readings and a film screening – was held in July at Haringey Recovery Service to launch the first issue. It has been distributed by hand to more than 70 locations including libraries and GP surgeries, both locally and nationally.

Everyone who contributes their time to the magazine receives Haringey time credits – a community currency that recognises voluntary support of other people and services, which can then be spent at a number of time credit partners. This helps the team to continue making The Worm, as they can use the time credits to rent meeting spaces or go to the cinema to review a film for the magazine.

Once the funding for the first issue has been used, the magazine aims to be self-funding, so the team are busy contacting local businesses and charities to invite them to advertise in future editions and keep the positive message going.

 

The Worm 1Founding member and editor-in-chief Jac Geraghty talks about how it all began

One day I had an idea for a magazine – and that idea was realised by extremely talented people, all of whom are in recovery.

We received funding for one issue from Haringey council’s Bright Sparks scheme. They gave us nearly £2,000, which allowed us to buy a computer and print our magazine. With this investment, we will be able to be self-sufficient in producing our upcoming issues, and the plan is to produce four a year.

We have also been greatly supported by Haringey time credits and Haringey Recovery Service – a partnership between St Mungo’s Broadway and alcohol support charity HAGA.

The idea came about during a tea break at Breaking Ground, part of the HAGA sustainment programme. It was then realised during the abstinence-based day programme, and has gone on to be a phenomenal success.

The plan behind The Worm was to hone and build on already established skills within our recovery programme. To be honest, it started out slowly, but once word spread we were inundated with ideas and contributions. We have a Facebook page, Twitter account, blog and, of course, our magazine. We are actively recruiting new members – from feature writers and researchers to sales and marketing managers.

I am extremely proud that The Worm has grown, and we are now a force of nature. The magazine is a community, and an extremely strong one at that. The Worm stands for Working to Overcome Recovery Misconceptions, and I think we are living up to that statement.

Spread the word – we are The Worm and we have arrived!

For more information, visit www.haringeyrecovery.org.uk or The Worm Facebook page, www.facebook.com/groups/790169471102851/

Recovery and drug treatment

Mark Gilman, Peter McDermott and Peter SheathTackling the deficit

Can an entrepreneurial recovery culture overtake an ailing treatment system? Mark Gilman, Peter McDermott and Peter Sheath examine the politics

‘Homophily’: the idea that if you want to stop smoking, overeating and getting divorced, you need to stop hanging around with smokers, fat people and divorcees. If you sit in the barber’s chair long enough, you’ll eventually get a haircut. If you’re seeking recovery it makes sense to hang around other recovering people.

Mutual aid groups are the obvious place to meet those people, but if you do throw yourself into recovery culture, be prepared to have pre-existing beliefs brutally challenged:

‘I’ve been thinking’

‘Stop it – your best thinking got you here.’

‘Take the cotton wool out of your ears and stuff it in your mouth. You might hear something that will save your life.’

‘Oh and get a job! Any job – it doesn’t matter what.’

Recovery narratives can sound moralistic, conservative and Conservative. Moral relativism is rare among people in long-term recovery. There are right and wrong ways of living. The right way is to get a job, pay your rent and care for your friends and family. The wrong way is methadone, booze, benzos and benefits; watching daytime TV while the state takes care of your kids.

In the aftermath of the general election we noticed something peculiar. There seemed to be a political, ontological divide between two tribes – those affiliated with the harm reduction model, and those affiliated with the recovery model. It didn’t seem to matter whether the person expressing the view worked in the field, or was in treatment/recovery themselves.

Harm reductionists saw the outcome as an attack on the entitlement to remain on long-term sickness benefits. They were supportive of a large publicly funded treatment system, which was threatened by the Tory victory.

Recovery messages were about voluntarism, about the need to take personal responsibility and building community – messages that were completely consistent with those of the Conservative government.

Despite Public Health England’s excellent facilitated access to mutual aid (FAMA) programme, few people make the journey from treatment services to mutual aid based recovery. There are exceptions to this and there is cause for optimism in those areas covered by the new grouping of commissioners for recovery who will find their collective voice via the British Addiction Recovery Group (BARG). The real problem for many community treatment service providers is that they simply cannot live with the uncertainties and risks of recovery:

‘These people – my patients, clients, service users – need me to do something. They might die if I don’t provide medical treatment.’

And of course this is true. Some patients might die if they attempt abstinence-based recovery. Life is a risky business but people with ambition and hope take these risks all over the world every day. Leaving the protection of methadone maintenance treatment may increase the risk of death. But it might also be the way to a brand new life beyond your wildest dreams, where you find jobs, homes and friends.

If successful, you might even create a firewall in the intergenerational transmission of addiction in your families. The question is, where should the responsibility for that decision lie? With the commissioner? With the service? Or with the patient themselves?

Again, this risk-taking, entrepreneurial approach to recovery can seem conservative and Conservative and at odds with the risk averse, managerial state bureaucracy where artificial targets, massaged figures and management speak replace experience, strength and hope.

At the moment we have a bureaucratic system measuring inputs and outputs such as access, retention and completion of treatment. In order to get a clearer picture of what drug treatment is actually achieving, we need to be measuring real world social outcomes such as jobs, homes and friends.

Take Successful Sid. Sid accessed methadone maintenance treatment as a heroin addict within days. He was retained there for years and left over six months ago. We can be sure that Sid won’t be returning to treatment because he is dead. People like Sid aren’t dying from acute opioid overdoses, they are dying from chronic physical health problems exacerbated by cheap alcohol – which he started drinking while in treatment.

It seems essential that we continue to look at which parts of the drug and alcohol treatment system work, and which parts are failing. The bulk of what happens in recovery actually happens outside of services – outside the formal treatment system.

Asset based community development (ABCD) has become something of a buzzword of late, but it is happening – often without any formal support or recognition. One strong example of a project based on ABCD principles is Jobs, Friends & Houses in Blackpool. It isn’t a treatment programme, but a business and a great example of a strengths rather than a deficits-based approach to the issues of drug and alcohol dependence.

At the UKRF conference in September, David Best argued that addiction/recovery are human rights issues, and the human rights deficit is most clearly shown by the exclusion of recovering people from the labour market. Programmes like Jobs, Friends & Houses provide an important model for how we can start correcting that deficit, but that’s just a single programme, in a single town.

Every year, thousands of people make the transition out of treatment into recovery in a very quiet, unsung way. Many want to reach out and offer the opportunities they have created for themselves to others seeking recovery who don’t want the formality of treatment or mutual aid within which to do it. Their politics is also probably more in line with the Conservative model of the Big Society, but rather than getting bogged down in labels and ideology, they just get on and do it anyway.

It’s always sad to see resources contracting in a field that you care about, but the truth is, drug treatment has been living high on the hog for much of the last 20 years. It’s going to be interesting to see the extent to which the reduction has an actual measurable impact on outcomes.

For the future though, we in the field need to start building on and making best use of those unpaid, unsung heroes who are delivering recovery both inside and outside the formal treatment system.

Mark Gilman is managing director of Discovering Health, www.discoveringhealth.co.uk; Peter McDermott is a policy professional and service user activist and Peter Sheath is senior associate with Emerging Horizons

Specialist recovery housing

No place like home

Phoenix Future’s new report Building recovery friendly communities makes the case for speciKaren Biggsalist recovery housing as a pathway to long-term recovery. Karen Biggs tells DDN why this is an opportunity not to be missed

From its unique position as both a drug and alcohol treatment charity and a housing association, Phoenix Futures has seen how pressures on the housing rental market are affecting people with drug and alcohol problems.

‘Changes in the housing world are increasing potential for people with substance misuse issues to have reduced housing options, either in treatment or when they exit treatment,’ says Phoenix Futures’ chief executive Karen Biggs.

At the same time, she points out, there are opportunities to bring together the housing and health agendas – ‘and if substance misuse isn’t in there when those conversations are happening, if we miss this opportunity, our service users will be seriously impacted… we will face the consequences further down the line.’

The charity’s new report (DDN, November 2015, page 4) sets out a housing pathway, starting with residential rehabilitation and moving through bridge housing – which prepares people to leave formal treatment – then into supported housing where they develop life skills, and on to recovery houses, and finally independent living.

‘This is what we think a housing pathway could look like in a local area,’ says Biggs. ‘It doesn’t have to be provided by one provider – use it as a starter to look at what you have in your area and how it supports someone as they’re moving through their recovery journey. Think about whether you are giving yourself the best opportunity to create that recovery friendly community.’

Phoenix are working effectively with partners in different areas, with the aim of making the housing recovery journey easier and helping people with tough choices.

Phoenix Futures housing 2‘Leaving treatment, housing options often restrict people from moving at their own pace and still getting the support they need,’ says Biggs. Working with other housing associations in some areas is proving effective in providing housing – independent living is central to the strategy they are now actively developing, and this involves finding landlords who understand about the recovery journey.

An understanding landlord can make a real difference to someone’s chances, she adds, as ‘if there’s a lapse they can be open and honest about it, rather than having to hide it from one of the most important stakeholders in their recovery. If there’s something that can be done to support them in independent living, that could be a conversation they could have with their landlord.’

Biggs hopes the document will open up a conversation between treatment providers, commissioners and housing providers. Many commissioners are already keen, she says, while community services have also welcomed the idea. Many housing associations also understand the issues, but there is a challenge in making sure these ‘don’t get lost’ with larger housing associations. Seeing initiatives come together can culminate in projects like Grace House, Phoenix’s new service in London for women with complex needs – the result of many conversations around how hard it is to achieve good quality, safe, stable housing for this group (and their families) and how hard it is for them to sustain treatment gains.

Keeping the service user at the centre of the model gave it clear direction from the start. ‘We came at it from a service user’s perspective,’ says Biggs. ‘We’d get them to think “what can I achieve before I leave?” and it’s about keeping that ambition. Peer support also played an important role: ‘It’s scary moving on to the next stage, so it’s helpful to see other people who’ve done it,’ she says.

Phoenix Futures housing 1Establishing a timescale for the recovery housing pathway involves a balancing act between being specific for the commissioner and being flexible enough not to impose too many constraints on the service user, particularly as ‘things get harder’ for them in the current climate.

‘Many of our service users have settled for “not good enough” when it comes to housing,’ she adds. ‘What we want to make easier is access to good, safe, secure housing and provide a full pathway. If we put the same effort into housing as everything else, it would be the best option for maintaining treatment gains.’

Building recovery friendly communities at www.phoenixfutures.org.uk

UK drug policy reform

Ian SherwoodOff track?

Drug treatment is being derailed by the sector’s refusal to push for reform, says Ian Sherwood

The distressing reality of drug dependence alters little over time, but society’s response to drugs and drug users has changed markedly over 30 years. During this time the field has developed an avoidance of the drug reform debate including decriminalisation, legal regulation and the role of criminal sanctions in treatment.

So why has this happened? The even-handed position we took then was usually a pragmatic one stemming from overriding priorities at the time; firstly to call for services for drug users in the 1980s, and then to argue the necessity and priority of harm reduction in the 1990s. Treatment providers were urgently distancing themselves from the moral panics stirred up in the tabloid press about drugs and HIV/AIDS, placing themselves within a safe, rational medico-therapeutic narrative.

For those on public platforms or official business representing treatment services it was a necessary but painful tactic to close down legalisation questions quickly, to ensure that the message about services wasn’t derailed by being ‘legalisers, soft on drug users’. Statements such as ‘my organisation is involved in treatment not politics’ became a default position.

It now appears that the parameters of acceptable debate have shifted to ‘recovery’ and little else. Despite a major upsurge in overdose deaths, talk of ‘harm reduction’ is increasingly taboo – and completely absent from government communications. The term ‘recovery’ has become a banner for anything broadly related to care, self help, therapy, coaching, training, social support, treatment and mutual aid. ‘Full recovery’ is the government’s preferred term, signalling a shift away from methadone towards abstinence-based interventions.

But the deployment of ‘recovery’ to mean everything to everyone leads again to the avoidance of debate and an inability to take positions. In 2015 this feels distinctly out of step with most informed opinion and global debate, disdainful of service user arguments for equality and social justice and ultimately negligent in reducing the risks and harms of drug use.

We all know that drug dependence only affects a very small minority of the many people who use drugs to the extent that they may require significant interventions. It is these clients of drug treatment services in the community and in prison that are cited by ministers as the justification for the Misuse of Drugs Act and the reason why legal regulation will not be entertained.

Treatment providers’ fear of biting the hand that feeds may have strong historical justification. But the factors that prohibition creates – a thriving black market with easy credit and violence – reduce the ability to provide treatment, undermine the communities in which drug use is most prevalent and demonise people who use drugs.

Now that’s what I call an obstacle to recovery and it’s time for the field to find its voice. It’s time to recognise that between those in recovery and those who provide treatment, care and support, there is a tremendous expertise that could articulate a way forward that is broad-based, constructive and reformist.

Disappointingly, it seems that the sector is content for almost anyone else to lead the way in this debate – even though it has potentially profound implications for them and their clients. Most recently police and crime commissioners have called for a ‘comprehensive review of strategy’ in a letter to the home secretary, with many chief constables also supporting reform.

When Portugal decided to decriminalise possession and replace it with a health response it wasn’t because they had discovered a radically effective approach to treatment; it was because they saw the criminal justice-led response as being both ineffective and harmful. In adopting a health-based policy they were choosing treatment approaches that have been used in the UK for more than 25 years – methadone, rehabilitation, detox, care planning, social reintegration – where people may still drop out of treatment, but can re-engage later without the threat of criminal sanctions.

Recent statistics on overdose in the UK are a depressing but timely corrective to the complacency regarding the success of drug treatment in the UK, and it seems very peculiar that no one is arguing for anything other than naloxone and training. It appears that an older cohort is dying, probably linked to the increased availability of imported heroin.

There hasn’t been any mention of drug consumption rooms (DCRs) – a widely researched, effective harm reduction intervention, again commonplace in Europe (and also found in Switzerland, Australia and Canada). Similarly, is anyone arguing for supervised injectable heroin – a well-researched intervention that comes under the heading of legal regulation? Surely if we are serious about wanting to stop people using and dying from illegal heroin we would look at quality evidence-based interventions for the hard to reach and the even harder to keep in treatment.

Another voice in the debate belongs to those who have been bereaved by drugs. The Families for Safer Drug Control group (now under the banner of Anyone’s Child, http://anyoneschild.org), are simply people who had lost a loved one to drugs and found the prohibitionist rhetoric hard to reconcile with their experience that in no way are drugs actually ‘controlled’ in the UK; all the laws seem to do is make drug use more risky and create vastly profitable, often violent, illegal marketplaces.

This, I would suggest, is the reality that most drug users, their families, service user organisations, the police and treatment providers see everyday – but the treatment providers aren’t talking about this, with some honourable exceptions.

Does your organisation take a position on drug reform? Take a look at the Count the Costs of the War on Drugs campaign (www.countthecosts.org), an in-depth and fully referenced resource on the reform debate, and sign up to examine the alternatives.

Ian Sherwood is a volunteer at Transform, www.tdpf.org.uk. He worked in drug treatment from the mid 1980s in voluntary and statutory sectors, as a clinician, manager and commissioner, and served three terms on the ACMD. He would love to hear from you at ian@tdpf.org.uk.

Benefits of therapeutic communities

RYinpragueAcademic notes

Drug sector veteran Rowdy Yates talks to David Gilliver about the value of therapeutic communities, and the therapeutic value of music

‘It’s kind of schizophrenic for me because one day I’m an esteemed academic doing my presentation and the following day I’m up on stage playing,’ says Rowdy Yates of last month’s annual conference at the San Patrignano community in Italy.

A passionate commitment to both therapeutic communities and music has defined his 46 years in the field, and although he resigns his post as senior research fellow at the University of Stirling at the end of this year, he’s staying on as president of the European Federation of Therapeutic Communities (EFTC) until 2017. And the community of San Patrignano (DDN, March 2014, page 8) is a shining example of what the sector can achieve, he believes.

‘It’s great,’ he says. ‘I mean, you’re talking about 1,500 people – it’s the biggest rehab in the world, really, and there’s a very strong, therapeutic community emphasis on self-help, self-governance.’

Is it a model that we could perhaps look at a little more closely in this country? ‘My view is that we could look at residential rehab much more closely and favourably than we do,’ he says. ‘We’ve had 20 years of thinking that residential treatment is profoundly expensive and therefore a last resort, and that means two things – one is that residential treatment has been marginalised, and the other is that it ends up treating the most chaotic, because you have to prove that you’re really, really messed up before you can get there.’

Much of the research comparing residential and non-residential models ‘doesn’t compare like with like’, he argues. ‘They’ll include the accommodation costs in the residential side of the equation, for example, but not in the non-residential side. I can understand why they do that, but the truth is that the majority of people receiving long-term methadone maintenance are probably also receiving housing benefit, so their accommodation is still costing the state. If you ignore that in an analysis then inevitably you make one side of the equation look more expensive.’ Studies rarely take account of the time window either, he states, with opioid-replacement therapy appearing affordable over the period of a year, but less so over ten.

One early ‘fundamental error’ of the harm reduction community was its failure to recognise, or effectively promote, the fact that it’s ‘actually about two things’, he says – reducing the harm that people do to themselves, and reducing the harm to other people.

‘The first is an entirely laudable aim, and one that’s entirely appropriate for drug treatment services. When I was running the Lifeline Project we were quite involved in needle exchanges and very clear that one of the major purposes was not just to reduce infection control, but also to look at how people were injecting and give them better advice. We kind of assume that long-term users know how to inject, but we forget that they were probably given inadequate advice when they started injecting, by people who’d also been given inadequate advice. We found long-term injectors who had appalling practices, which we were able to correct.’

Reducing harm to others, however, is something he’s ‘less convinced’ that treatment services ought to be involved in. ‘We can’t deny our responsibility to the community, but I know of a number of services who have workers going around giving clean needles and syringes to weightlifters who use anabolic steroids. Now there’s no indication that these people are addicted to those substances – so this is not addiction treatment, it’s not about resolving their drug problem, it’s about infection control.’

It’s possible that many people would be happy for treatment services to move away from a focus on addiction towards public health, infection control and crime reduction, he says, ‘but I’m not aware that we’ve ever had that debate. So that would be my reservation.’

An unintended consequence of harm reduction was to ‘effectively change the face’ of drug treatment, he believes. ‘Up until that point we were the good guys, taking people who were using drugs and making them better. After that, our priorities reversed. People who didn’t want to get better became our priority, and what we did with them in many cases, I suspect, was prolong their addictive experience. I continually meet people in therapeutic communities who tell me they were prescribed methadone for 15, 16 or 20 years. They feel angry about that and argue – with some validity, I think – that that prescription practice actually extended their addiction career.’

It’s a situation that in some ways reflects his entry into the field in the late 1960s, he says, which came via his own heroin use and a belief that if people wanted effective support they’d need to create it themselves. ‘A group of us ex-heroin addicts had been attending Alcoholics Anonymous, which at that time was about the only game in town. Drug dependency units, as they were known, were prescribing heroin and clearly didn’t believe in recovery, and really the whole of mainstream treatment in the UK and the states didn’t believe in recovery. So we decided we’d set up our own little support group.’

The spark was one member of the group coming across Lewis Yablonsky’s book, Synanon: the Tunnel Back, an account of a group of heroin users living together in a Santa Monica house – the Synanon community, later the subject of much controversy – but ‘not using’, Yates points out. ‘New York City probation department sent a group of experts out including Yablonsky, who was a sociologist, and he was so impressed that he didn’t come back. He stayed for a year and wrote the book. We read it and thought, “We could do this”.’ A priest provided an empty rectory building for very little rent and the group ‘just moved in, started doing it up and running our own therapeutic community – based on little more than Yablonsky’s description of how it worked’.

It was this community that ultimately led to the establishment of the Lifeline Project in the early 1970s, of which Yates later became director – ‘an addict who got lucky’, as he’s described himself, putting much of that good fortune down to the support of influential peers and mentors. ‘I’ve been very, very lucky in that respect’ he says.

Does he feel that the value of therapeutic communities has been properly recognised, or is there still a way to go? ‘No, there’s a very long way to go, and unfortunately I think the track we set out on was the wrong one, and we’re still reeling from the damage that caused. In my view, one of the major mistakes therapeutic communities made was to accept that they were about drug treatment. That effectively made them part of the health service, measured by those kind of randomised control trials that are very, very difficult to implement in such a complex intervention. There’s an argument that we took the shilling and became special hospitals, when really we should have become special schools.’

What such communities are really about is people learning to live and behave in a different way, he believes, and helping each other to do that in a structured environment. ‘That’s not really about drugs, and I’d like to see a big extension of therapeutic communities to many other areas – areas where, coincidentally, they’ve already begun to work,’ he says, pointing to those now seeing significant numbers of young women who self-harm as well as survivors of abuse or trafficking. ‘Those are areas that are entirely appropriate for that community-as-method approach. In some respects we’ve hamstrung ourselves into being simply about drug treatment, and I don’t think the approach is simply about that. I think it’s much broader.’

Is it too late to reverse that now? ‘I think so,’ he says. ‘One of the problems therapeutic communities and other residential agencies have faced over the last 20 or 30 years is the hijacking of some of the radical psychiatry notions about closing down big psychiatric institutions and moving people into the community. Right-wing governments – like Margaret Thatcher’s – hijacked that notion because they saw an opportunity to save huge amounts on health costs, not because they thought people could be cured in the community but because they thought, “We can close down this massive loony bin and sell it to Tesco”.’

That bred a notion of ‘residential bad, community good’ that still exists, he argues. ‘But I think we’re beginning to move out of that and recognise that it’s not really about residential and non-residential, it’s about treatment dosage. Some people will need a higher level of treatment intensity, a bigger dose, and the most effective way of delivering that is probably in a residential setting.’

The last decade or so has seen more and more people ‘fed up with being prescribed medicine for a social condition’, he says, or ‘seeing that happen to their relatives. It reached critical mass and they said, “We want something better”, something that mirrored the period in the late 1960s and early ‘70s when therapeutic communities originally appeared. You had a group of drug users, supported by radical psychiatrists, saying, “We can do better than this” and mainstream treatment saying, “No you can’t – the best we can do is control the whirlwind”. This belief in recovery is cyclical, I think, and we’re in one of those waves now.’

As the field continues to evolve and change, how does he feel about his imminent retirement from it? ‘I think it’s time, really, although I’m going to retain some of my responsibilities. Looking back, the major milestone for me was being made Phoenix Futures’ first – and only – honorary graduate. That was far more important to me than my MBE or other appointments over the years.’

His retirement will also give him the time to indulge his other passion, music, and his band Running wi’ Scissors plans to record an album to help raise money for therapeutic communities early next year.

‘I love playing music, but I kind of came out of it for a number of years and didn’t play at all, because for me my involvement in it was associated with my involvement in drugs. That’s where I started, when I was playing in bands in the ‘60s, so I kind of saw the two things together. I was frightened to play music, I suppose.’

The value of music and other creative activities in people’s recovery is something else that remains hugely under-appreciated, he says. ‘Music and drama and dance are often seen simply as ways of filling residents’ time – something they can do in the evenings. I think it’s much more important than that. We know from studies that playing music fires off synapses in the brain that don’t otherwise fire, so it has a profound effect on people’s thinking and self-esteem. That’s a really interesting area to explore.’

November DDN 2015

DDNnov15

In this month’s issue of DDN…

‘Talk of “harm reduction” is increasingly taboo – and completely absent from government communications.’

In the latest issue of DDN, Ian Sherwood asks whether drug treatment is being derailed by the sector’s refusal to push for reform.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page. 

PDF Version / Virtual Magazine

Families First evening event

[contact-form-7 id=”12521″ title=”Families first evening event”]

Minimum pricing ‘could breach EU law’

The Scottish Government’s plans to introduce minimum unit pricing for alcohol could potentially breach EU free trade laws, according to an initial ruling by European Court of Justice advocate general Yves Bot. While the move would not be precluded by EU legislation, it would be legal only if it could be proven that it was the most effective public health measure available, he stated. The decision has been seen as a significant setback to the government’s plans.

In the case of The Scotch Whisky Association and others versus the advocate general for Scotland, Mr Bot ruled that ‘in order to pursue the objective of combating alcohol abuse, which forms part of the objective of protecting public health, a member state can choose rules imposing a minimum retail price of alcoholic beverages – which restricts trade within the European Union and distorts competition – rather than increased taxation of those products, only on condition that it shows that the measure chosen presents additional advantages or fewer disadvantages by comparison with the alternative measure.’

Increasing taxation would be ‘capable of procuring additional advantages by contributing to the general objective of combating alcohol abuse’, he stated.

Scottish first minister Nicola Sturgeon, however, has stressed that the legal process is still ongoing and that a final response from the European Court of Justice is needed before the case can return to the Scottish courts. ‘This initial opinion indicates that it will be for the domestic courts to take a final decision,’ she said.

‘While we must await the final outcome of this legal process, the Scottish Government remains certain that minimum unit pricing is the right measure for Scotland to reduce the harm that cheap, high-strength alcohol causes our communities,’ she continued. ‘In recent weeks statistics have shown that alcohol related deaths are rising again and that consumption may be rising again after a period of decline. We believe minimum unit pricing would save hundreds of lives in coming years and we will continue to vigorously make the case for this policy.’

Opinion of advocate general at http://curia.europa.eu

Comment from the substance misuse sector

Letters and comment

LettersDDN welcomes your Letters Please email the editor, claire@cjwellings.com, or post them to DDN, CJ Wellings Ltd, 57 High Street, Ashford, Kent TN24 8SG. Letters may be edited for space or clarity.

 

Marteau complex

We were shocked to see the title of a key article on the cover of last month’s DDN, Kill or cure: the dangers of diverted methadone. DDN’s approach was more in keeping with a tawdry tabloid splash rather than its usually more balanced magazine. Dave Marteau’s article asks: is it time ‘to reappraise our relationship with the life-saving drug methadone?’ He says he will discuss the evidence and this is what we want to challenge.

He starts with how methadone reduces deaths by 50 per cent, reduces HIV infection and how it has been positively evaluated by NICE. Then it seems as if Marteau does not know that methadone and buprenorphine are very different drugs. It is no revelation that methadone is potentially more dangerous than buprenorphine. Thus they are in different legal classes and schedules – unusually a sensible use of the classification system. But simply saying methadone is more dangerous than buprenorphine is like saying insulin is more dangerous than oral hyperglycaemic drugs and therefore we shouldn’t prescribe insulin.

He references the Auriacombe review of drug-related deaths in France between 1994 and 1998, which found buprenorphine was safer. This was when buprenorphine was first licensed and was first used in primary care and prescribed to people with less complex issues. This is a very important point. Many of us writing here are clinicians and have between us many, many years of experience. We will have cared for thousands of patients with drug problems and as a broad generalisation, the more complex, vulnerable, more likely to overdose and sick patients were settled much better on methadone and few of this group did well on buprenorphine. Keeping these patients in treatment is the most important thing – especially at the start. So using the medicine that does this most successfully is the obvious and right thing to do.

In his own study on which this article is based, The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales Marteau D, Macdonald R, Patel K. BMJ Open 2015; 5:e007629, they used fairly simple drug-related mortality data from two sources but posed some complex questions. We feel there is not nearly enough data to make any recommendation on ‘safe or unsafe’ prescriptions from this paper. Marteau needs to recognise that the nature of methadone – or buprenorphine – related deaths is a very broad church and association does not necessarily imply causation in all cases.

It is also an area where reporting bias may feature. In the Bell study there were 60 sudden deaths positive for methadone (32 in treatment) and seven buprenorphine-positive decedents (none in treatment). Most out-of-treatment deaths occurred in people with known histories of drug misuse, so is this a failure by drug services to engage with people? Might the diverted methadone actually be keeping many people alive who aren’t able to access treatment or couldn’t manage daily supervision? Also, isn’t it possible that those who were in treatment were inadequately dosed and self-treating with street methadone? It’s notable that the average dose of methadone across the six years of the Marteau paper was 46.6mg per day, way below the accepted therapeutic dose – what part did this play?

Using a single study, which like any academic paper has weaknesses as well as strengths, to suggest blanket recommendations on policy is indefensible. It’s a sensationalist, self-aggrandising approach that does an enormous disservice to public health. Methadone has many complex issues but it is a medication that has saved many lives in this country and around the world and continues to do so. Of course the issue of diversion is important and should be dealt with, but this article is at the very least unhelpful, and at the worst dangerous, particularly in this climate of rising poverty, social exclusion and drug-related deaths.

We implore Marteau to think seriously about the limitations of his paper before recommending potentially dangerous and unjustified policy changes.

Dr Chris Ford, clinical director, IDHDP; Dr Euan Lawson, deputy editor, British Journal of General Practice; Dr Clare Gerada, GP and ex-chair RCGP; Dr Judith Yates, GP and chair IDHDP; Dr Roy Robertson, professor of addiction medicine, Edinburgh; Dr Garratt McGovern, specialist GP, Dublin; Niamh Eastwood, executive director, Release; Dr Icro Maremmani, president, World Federation for the Treatment of Opioid Dependence; Dr Alex Wodak, emeritus consultant, Alcohol and Drug Service, St Vincent’s Hospital, Australia; Dr Robert Newman, director, Baron Edmond de Rothschild Chemical Dependency Institute, US; Joycelyn Woods, executive director, National Alliance for Medication Assisted Recovery, US; Dr Jasna Čuk Rupnik, MD, Center for Prevention and Treatment of Addiction of Illicit Drugs, Slovenia; Professor Barbara Broers, vice-president of the Swiss Society of Addiction Medicine; Dr Herman Joseph, NAMA, US

 

Dave Marteau responds:

I am reassured that experts now all seem to agree that methadone is more dangerous than buprenorphine. The published evidence to date indicates that it is around five times more lethal. Again, all seem to agree that methadone diverted from the treatment system is the main source of these tragedies. A total of 2,366 of our fellow citizens dying with methadone in their systems in just six years is hundreds, if not thousands, too many.

I have already given my views on this very important subject, so I (and I imagine DDN) would welcome the thoughts of other readers.

 

DDN is a non-partisan forum for debate and all views are welcome.

Editor

 

Red alert

I work in an emergency accommo­da­tion facility, and I recently completed a two-day trainer course on naloxone. Now we have been told we cannot store naloxone on the premises – neither will they fund a kit for myself! Red tape gone mad… again!

Jim Kirkwood, Glasgow

Local news from the substance misuse field


Prison visitDuchess of cambridge visits treatment programme

The Duchess of Cambridge visited HMP Send this month to see a RAPt addiction service in action.
The programme, based in a standalone women-only unit, is an intensive 12-step drug and alcohol programme. The Duchess heard personal stories from some of the women about their experiences with addiction and crime, and how the programme was helping them to overcome their addiction.

‘I was reminded today how addictions lie at the heart of so many social issues and how substance misuse can play such a destructive role in vulnerable people’s lives,’ she said. ‘I saw again today that a failure to intervene early in life to tackle mental health problems and other challenges can have profound consequences for people throughout
their lives.’
Film festRecovery film festival draws to a close

The Recovery Street Film Festival ended its nationwide tour in Sheffield on 26 September, after showcasing short films made by people in recovery to audiences across the UK to raise awareness of drug and alcohol problems.
The pop-up cinema event – organised by Addaction, Action on Addiction, Blenheim, Northumberland Recovery Partnership, Phoenix Futures and Turning Point – toured across Durham, Blyth, Manchester, Glasgow, London and Sheffield over two weeks during recovery month.

The aim of the festival was to reduce stigma surrounding drug and alcohol problems by showing the public three-minute films of personal accounts of addiction and how people’s lives have changed. The top ten films entered into a competition run earlier this year were chosen by a panel of judges, with the top three entries winning £1,000 worth of prizes.

‘The Recovery Street Film Festival has been a huge success and we received a great response from members of the public and people in recovery who volunteered to help run the individual events,’ said Bob Campbell, Recovery Street Film Festival organiser. ‘We hope the festival has challenged the public’s views about people who have overcome addiction, and given hope to people who are currently being affected by problems with drugs and alcohol that there is possibility of a better future.’

 

Primary schools asked to think again about alcohol

Drug and alcohol charity Swanswell is asking primary schools to re-evaluate their relationship with alcohol at events such as school fetes and sports days.

Research by the charity suggests that around one in three primary schools in England are serving alcohol to adults at events aimed at children. Swanswell is calling for a change to licensing laws, so that any application from a primary school to serve alcohol at events aimed at children is refused. It is also asking schools to think again before gifting alcohol in raffles or allowing children to take in alcoholic end of year gifts for teachers.

 

Hope festivalTruro festival celebrates recovery

A ‘festival of hope’ was held this month at Boscawen Park in Truro to celebrate the recovery successes of people in Cornwall.
The day, organised by Addaction volunteers and staff, was opened by Truro’s mayor Cllr Lorrie Eathorne-Gibbons. To keep the crowds entertained, there was live music, good food and local stalls – as well as the opportunity to hear from people who shared their own stories of recovery and volunteering.

The event raised more than £1,000 for Addaction’s Cornwall recovery cafés. One volunteer, Mat Wilkin, raised £500 himself by having his head shaved on the day.

 

StoptoberService users offered support to quit smoking

Local people in recovery in Doncaster are being offered support to help them quit smoking.

Staff from Doncaster Drug and Alcohol Service (DDAS), run by Rotherham Doncaster and South Humber NHS Foundation Trust (RDaSH), have been trained to give stop smoking advice and are working with individuals to try to reduce their risk of premature death.

A number of service users have already quit since the start of 2015, and DDAS is encouraging those who use its services to take part in the ‘Stoptober ‘challenge. DDAS will be offering support, as well as nicotine replacement, across all its Doncaster premises.

Alcohol and drugs in the news

Media savvy

The news and views from the national media

Laws against smoking have irreversibly shifted attitudes. The same drive is needed for alcohol consumption. The police, magistrates and judges must insist on rehab for alcoholics as they do for drug addiction. And finally, while the NHS must care for those already addicted, it needs to get tougher on those who won’t stop drinking till they are blotto. Inform their employers or the benefits office. Show them there is no such thing as a free bed. Shifting a culture is not easy but it can be done.

Yasmin Alibhai-Brown, Independent on Sunday, 6 September

The [charity] sector is crying out for rationalisation through merger. It’s been talked about for years; but the holier-than-thou approach many charities take to their cause, combined with their ad hoc back offices, means that there’s little motivation to develop in this way… We need a Big Bang in the sector, with potential and existing charities required to justify why they are not joining others sharing the same purpose.

Matthew Patten, Telegraph, 3 September

People refer to our culture as ‘alcogenic’. It isn’t, it is alcophiliac. Drink is not merely the socially acceptable addiction, but the socially approved fix. Alcohol is how our society detaches itself from stress, be it the angst of work or parenthood. It is how it celebrates and mourns, marks the holiday and the everyday. Millions of people – like me – come under the category ‘functional alcoholic’, as if the ‘functional’ somehow negates the disease.

Hannah Betts, Telegraph, 14 September

The debate on minimum pricing for alcohol will now switch from the courts to the academic arena and the researchers will be asked to provide the proof of the policy the government wants to implement. When a government looks to academia to provide evidence for its favoured policy we should all be uncomfortable. Universities love government funding – they depend upon it. So the temptation will be to accept the government’s largesse and to deliver the findings the government wants to hear. Only in this case, the audience will not be sympathetic Scottish Government ministers, but sceptical European legal experts.

Neil McKeganey, Scotsman, 7 September

A mother who paid £300 for a dozen packets of cocaine as a birthday present for her daughter’s 18th has been spared jail. Nicola Austen, 37, with six previous drugs convictions, expected to be sent to prison and turned up at Maidstone Crown Court with an overnight bag. But the judge gave her a suspended sentence and community service because she is a ‘carer’ for her 14-year-old son and her elderly grandmother. Run that by me again. A woman who buys cocaine for her teenage daughter is spared jail because she is considered a suitable person to look after a 14-year-old boy? Am I missing something here?

Richard Littlejohn, Mail, 11 September

Drug poisoning deaths hit highest level ever

Last year saw England and Wales register the highest number of drug poisoning deaths since records began more than two decades ago, according to figures from the Office for National Statistics (ONS).

There were 3,346 drug-poisoning deaths registered in 2014, almost 70 per cent of which involved illegal drugs. The figures came just over a week after Scotland also recorded its highest ever number of drug-related deaths for the same period (DDN, September, page 4).

Deaths involving heroin and morphine increased sharply between 2012 and 2014 – from 579 to 952 – while deaths involving cocaine also jumped dramatically, from 169 to 247 in the space of a year. Cocaine-related deaths have now increased for three years in a row, reaching an all-time high of 4.4 per million population. However, while England saw a 17 per cent increase in its drug misuse mortality rate – to 39.7 per million population – Wales saw its proportion drop by 16 per cent to 39.0 per million, the lowest figure for almost a decade.

In England, the north east had the highest mortality rate and London the lowest. As was the case in Scotland, most deaths occurred among older people, with the highest mortality rate in the 40-49 age group, followed by those aged 30-39.

Treatment charity Addaction said the stark figures meant the government now needed to rethink its proposed cuts in local authority health spending (DDN, September, page 4). ‘Drug treatment services across the country have seen an increase in the number of people seeking help for opiates and/or crack cocaine, and this is only likely to increase further as the effect of increased opiate availability and purity is felt,’ said chief executive Simon Antrobus. ‘Meanwhile, the Department of Health are proposing a £200m reduction to the public health grant, which will hit the capacity of drug services commissioned by local authorities.’

The government needed to ensure local authority health spending was given the same amount of protection as that promised to NHS-commissioned services, he stated. ‘The stakes are simply too high to do otherwise.’

Deaths related to drug poisoning in England and Wales, 2014 registrations at www.ons.gov.uk

Post-its from practice

Steve BrinksmanSometimes the drug or alcohol problem isn’t obvious, says Dr Steve Brinksman 

Marco rarely came to the surgery. He was a 44-year-old restaurant owner with two young children but on a routine screen had been picked up as having high blood pressure. He had been given advice to lose a little weight and exercise more, but this made no significant difference. He was started on an anti-hypertensive and his blood pressure improved; but 12 months later it was up again, and as he was adamant he was taking his medication every day, a second drug was added in.

Three months later one of our registrars noticed his blood pressure was again poorly controlled. Rather than add in a third drug she decided to discuss this with me as part of her learning portfolio.

We went through his notes. He had been overweight but his body mass index (BMI) was now 26, so this was unlikely to be a significant factor. He had stopped smoking when his first child was born seven years earlier, his renal function was normal and no significant past medical history was recorded. I asked her if he drank alcohol. ‘I’m not sure,’ she said and indeed nothing was recorded in his notes about alcohol consumption. I explained that excessive alcohol use was a major factor for hypertension and cardiovascular disease.

He was due for review the following week and after this we caught up. He had told her he drank a bottle of red wine every day, as it was good for his heart! She had explained to him about the effect alcohol has on high blood pressure and cardiovascular disease and he had been shocked by this. He decided to try and cut his alcohol down rather than take a third medication. His blood pressure improved over the next few weeks and it was possible to stop one of his tablets.

I was the next person to see him and this time his blood pressure was within the normal limits while he was still taking a single drug to control it. He told me he had reduced his alcohol to half a bottle one night during the week and half a bottle each day over the weekend.

I wonder how many patients have physical and mental health problems related to their drug or alcohol use that pass unnoticed because a health professional doesn’t ask. We are trained to ask difficult and/or embarrassing questions, yet so often we don’t.

As part of our commitment to improving the treatment of alcohol users, SMMGP have launched an online training module about the community management of alcohol use disorders which can be completed free of charge at www.smmgp-elearning.org.uk

Steve Brinksman is a GP in Birmingham and clinical lead of SMMGP, www.smmgp.org.uk. He is also the RCGP regional lead in substance misuse for the West Midlands.

National news from the substance misuse field

A round-up of national news – October 2015

Emergency inquiry

An inquiry into the impact of alcohol-related incidents on the emergency services has been launched by the All Party Parliamentary Group on Alcohol Harm. Alcohol-related harm costs the NHS an estimated £3bn per year and puts intense pressure on services, particularly at weekends. A central objective of the inquiry will be to ‘build a clear picture’ of the time and resources lost to alcohol, said group chair Fiona Bruce MP.

 

An involving document

A new guide detailing the benefits of involving recovering drug and alcohol users in treatment design has been published by PHE. The guide sets out the different levels of user involvement, with useful examples of good practice. ‘Those who have recovered from addiction themselves have the experiences, and often the expertise, to help others and can make an important contribution to the development of successful services,’ said PHE’s director of alcohol, drugs and tobacco Rosanna O’Connor. Service user involvement: a guide for drug and alcohol commissioners, providers and service users at www.gov.uk

 

Götz goes

Alexis Goosdeel has been appointed as the new EMCDDA director, the agency has announced. He takes up the position next January, replacing Wolfgang Götz, who has held the post since 2005. Mr Goosdeel has been at the EMCDDA since 1999, before which he co-founded Belgian harm reduction NGO Modus Vivendi.

 

BBV boost

A new briefing to support local authorities and drug services in reviewing their BBV prevention and treatment interventions has been published by PHE. Preventing blood-borne virus transmission among people who inject drugs draws together published evidence and guidance, as well as feedback from treatment services. Available at www.nta.nhs.uk/r-Evidence%20and%20Guidance3.aspx

 

Boundary change

‘Locally-led and coordinated’ action is vital to support people with multiple and complex needs, according to a new report from the Institute for Public Policy Research (IPPR). Public spending on individuals experiencing problems like addiction, homelessness and offending is still ‘largely reactive’, says the document – preventative support would deliver better results and save money by avoiding duplication and avoiding the need for expensive crisis care. Breaking boundaries: towards a ‘troubled lives’ programme for people facing multiple and complex needs at www.ippr.org

 

Penalty points

A new tool to instantly compare the penalties for drug possession and supply across Europe has been developed by EMCDDA. Searches can also be refined according to drug type, quantity and the ‘addiction or recidivism of the offender’. Penalties for drug law offences in Europe at a glance at www.emcdda.europa.eu

Substance misuse safeguarding

Kevin CrowleyOn the safe side

We mustn’t be afraid to engage with parents about sensitive safeguarding issues, says Kevin Crowley

As a social care and health charity, CRI works with individuals, families and communities across England and Wales affected by drugs, alcohol, crime, homelessness, domestic abuse, and antisocial behaviour.

Working with this at-risk group of people, it is imperative that certain safeguards are observed. Service users who seek our help are often in an extremely vulnerable position and may need support with not only the physical effects of substance abuse, but with the effects it can have on their lifestyle, family and professional lives. Our priority is to always help service users create a safe environment, which will ultimately help their recovery process.

Safeguarding particularly applies when the service user is caring for children. As an organisation, CRI has a shared responsibility to ensure that the children of parents struggling with alcohol or substance misuse are safe and protected. While we can never completely eliminate risk, we put our energy and resources into reducing it as much as possible.

A key concern for these often vulnerable children is to limit, as much as possible, exposure to substances. At CRI, we treat heroin-dependent service users with opiate replacement medications which are by their nature potentially dangerous drugs. Any service user who is given methadone, for example, will be provided with a safety-locked box that will prevent children from directly accessing it. Staff conduct home visits, starting from as close to the initial distribution as possible. A vital aspect of these home visits is to ask questions and not make assumptions, as well as educating parents on the risks posed to children around medication. Frontline staff are trained to use their expertise and professional initiative to assess the home environment of a child.

We work with multiple organisations across the social care sector, including local auth­or­ities, police, and social services, to provide a well-rounded and holistic care system. Collaboration and communication is key to giving parents the best possible support, ensuring that separating a child from its parents will only ever come as a last resort. As a drug and alcohol rehabilitation charity, we support parents with substance issues but will always work with or refer cases to other organisations, should their expertise be better placed.

Our safeguarding approach at CRI is to do everything we can to minimise risk. In an ideal world we would reduce risk to zero, but as we are often tragically reminded, in the real world of recovery this is not possible. A fundamental principle is working with our service users and other professionals openly and collaboratively, and not being afraid to engage with them on risk and safeguarding issues. Welfare of their children is not only paramount for us but for the vast majority of parents in recovery.

Kevin Crowley is executive director of quality, governance and innovation at CRI

Experts on safeguarding will be speaking at a national conference in Birmingham on 10 November, presented by Adfam. Details and booking at www.drinkanddrugsnews.com/safeguarding-conference

 

 

Recovery month 2015

Recovery round-up

Throughout September, thousands of people across the UK got together to celebrate recovery – with fund-raisers, festivals and plenty of fun. DDN gets a glimpse of some of the action.

Getting stronger

With more recovery events taking place than ever before, UKRF founder Alistair Sinclair looks at why UK recovery month is going from strength to strength

On 1 September 2013, around 100 folk climbed Snowdon to mark the beginning of the first UK recovery month. While recovery month has been celebrated in the US for many years, and the UK recovery walks started with a memorial walk in Liverpool in 2009, 2013 was the first year we saw a range of recovery activities all over the UK in September. There were 49 events in 2013, and 2014 saw 102. This year, we’re aware of 166.

Recovery month 2015 kicked off in Manchester at the seventh national UKRF event, where around 250 UK activists gathered to explore the role of recoverists in an ‘age of dislocation’. Thousands of people made recovery visible at recovery walks, around 26 of them across the UK – including walks in Dublin, Glasgow and Durham.

Other communities held family fun days, music festivals, dance events, film nights, harm reduction cafés, plays, sports events, workshops and unity days. One recoverist, Lexi West, set off to climb to Everest Base Camp to raise funds for recovery communities and plant flags for the fallen.

The variety of events in recovery month and the passion behind them was incredible and inspiring. It was a month dedicated to community building and hope. The UKRF believes we all need a month like this – highlighting our similarities as human beings, the core values that connect us and the belief that we can, all of us, recover.

www.ukrf.org.uk

Recovery festival

Walk this way

The UK recovery walk has just completed its seventh year on the trot. Its founder Annemarie Ward talks about how it’s kept up momentum

This year, the annual UK recovery walk was held in Durham, writing another chapter in the history of addiction recovery in the UK. At the recovery, spirituality and families conference in Durham Cathedral the day before the walk, and during the walk itself on Saturday 12 September, we went some way in challenging the social stigma attached to addiction. The UK recovery movement has matured further this year. As in our personal recovery, masks of arrogance and intolerance give way to greater humility and acceptance, and as a movement overall we have celebrated greater unity in strength and experienced greater strength in unity.

There have been many people who have worked tirelessly to make sure recovery month events went off without a hitch. It’s fantastic to see it go from strength to strength. With the conference and the walk in Durham this year, many of the people of the north east got to know, see and feel what recovery is.

As a charity, we are grateful for that, and even more so for how the people of the north east worked with, cared for and loved us. Our sincerest gratitude goes to every single person who played a role in international recovery month.

Going for gold

Neil Firbank of New Beginnings recaps the activities of this year’s recovery games

Wow, did this year’s games really exceed our expectations! We knew, based on the last one, that it would be popular, but I never expected that 25 teams would turn up on the day. That meant in total around 400 competitors took part, battling against each other in a wide variety of events.

The games drew around 300 spectators, from family members and the local community, who were all amazed at the message we were spreading, and hopefully went some way to reducing the stigma faced by those taking part.

The original idea for the games came from watching how the Olympics 2012 really pulled everyone together and ignited a community spirit. I wanted to organise an event that somehow captured that, and showed people that we do get better – that you would never believe that the person next to you could ever have had issues with substances. It also had to be fun.

Eventually, the games drew to a close with five teams facing each other in a grand finale of didicar time trial racing. Active Recovery from Scunthorpe came away the overall winners, and took away the coveted recovery games shield.

The games turned out to be a fantastic day, and we managed to raise over £500 for Aurora, a local cancer respite charity. Watch this space for next year’s recovery games – it can only get bigger and better.

www.drughub.co.uk

Recovery festival 2

Moving forward

Forward Leeds staff, volunteers and service users also attended the UK recovery walk to meet and connect with the local recovery community. The walk led crowds through the city centre, past Durham Cathedral, and provided live music, stalls and activities – as well as a performance by the UK recovery choir and rap artist Ben SoS Riley.

The Le Tour de Recovery also joined the walk, after cycling to Durham from Leamington Spa. The ride raised money for UK FAVOR, as well as awareness for the importance of communities sustaining recovery.

Festival feeling

Jack Hall of Bristol Drugs Project shares what went down at the third recovery festival

This year’s festival captured its biggest audiences ever, with attendees from recovery communities across the south west.

Established in 2013, the recovery festival is a free annual event that celebrates recovery from addiction by bringing people together to share their strengths, hopes, achievements and, most importantly, their talents.

This year’s festival featured an array of local musicians, as well as fantastic performances by Bristol’s recovery choir Rising Voices and the Bristol Drugs Project theatre group. Topping the line-up were guest speakers Annemarie Ward, founder of the UK recovery walk, and Tony Mercer of Public Health England.

The day featured a selection of great food and refreshments, as well as alternative therapies, taster support groups, and the opportunity to browse the stalls of local communities and services to find out what opportunities are available to people thinking about treatment, or in recovery.

www.therecoveryfestival.co.uk

Recovery festival 3

Harm reduction at the NNEF meeting

On the front line

MMatt Johnstoneatt Johnstone brings harm reduction news from the annual NNEF meeting 

The National Needle Exchange Forum (NNEF) held its annual meeting in Birmingham last month. The meeting brings together members of the NNEF to present the latest news and updates on harm reduction for needle exchange workers, harm reduction advocates and service users, with a number of exhibitors including Frontier and Exchange Supplies displaying the latest products for needle exchange programmes.

There were presentations on the latest developments on naloxone and updates from Public Health England (PHE), as well as updates on the work of the NNEF over the past year. Alongside some of the presentations there were overdose and naloxone training sessions, delivered by NNEF deputy chair Philippe Bonnet and Kevin Jaffray.

Naloxone changes ‘just a start’

The morning sessions focused on updates and changes to legislation regarding the provision of naloxone. Kirstie Douse from Release presented the legal implications of the changes, highlighting that the new regulations are a good start but don’t go far enough as there is still no national programme or requirement to provide naloxone, resulting in a postcode lottery.

Nigel Brunsdon spoke about practical ways to embed naloxone provision into services, showing the importance of developing protocols and policies as well as working with local partners to raise awareness.

‘When it comes to starting naloxone within your service, it is so important not to let the development of paperwork be a barrier to getting started,’ he said. ‘However we do need to monitor the programmes to evidence the effectiveness to others, as well as working with commissioners at all levels to make naloxone provision a key performance indicator.’

NNEF 1Policy updates

Speakers from PHE and the Home Office provided the latest news from public health. Among them were Viv Hope who outlined the recent emergence of mephedrone injecting in the UK from the unlinked anonymous monitoring survey (UAM) among people who inject drugs. He highlighted that ‘there are higher levels of risk and infections among those who have injected mephedrone, with one in 12 among survey respondents having injected mephedrone within the last 28 days.’

‘Interventions needed’

Katelyn Cullen from PHE drew insights from the UAM survey into neck injectors, outlining that interventions are required to improve injecting technique and reduce misconceptions around this practice.

There were also updates from the Home Office with David Ryan-Mills looking for services to get involved with their plans to evaluate foil provision in England.

NNEF developments

Jamie Bridge, chair of the NNEF, gave an overview of the work completed by the NNEF within the past year, including the creation of a directory of all the needle exchanges in England following the Freedom of Information request to 152 directors of public health.

‘NICE guidance recommends that directors of public health ensure that services are commissioned to deliver a range of generic and targeted needle and syringe programmes to meet local needs,’ he said. ‘Without a central database or map of exchanges, it is difficult to assess the implementation and coverage of NSPs.’

As deputy chair of the NNEF, I launched the ‘secret shopper’ project to assess the service offered by NSPs within drug services and pharmacies. The main aims are to assess the availability of access to clean injecting equipment, and whether people accessing NSPs are treated with dignity and respect.NNEF 2

The NNEF is currently recruiting service users, service user groups and harm reduction advocates to become secret shoppers to find out what is happening in the real world.

The day finished with keynote speaker Sara McGrail, who gave an inspirational presentation on what the increase in drug-related deaths might be telling us about our drug treatment system. Highlighting the concerns for the sector with the de-prioritisation of harm reduction, changes in the culture of drug services in England as well as the impact of service commissioning and recommissioning every few years, she called for the ‘urgent and focused thematic CQC review of service and commissioning, including contracts in those areas which have the highest rises in opiate-related deaths.’

For more information about the presentations and to join the NNEF (membership is free) visit www.nnef.org.uk

Matt Johnstone is deputy chair of the NNEF

Pics by Nigel Brunsdon

Addictive behaviours conference

The appliance of science

The first pan-European multi-disciplinary conference on addictive behaviours looked at how science and research can translate into policy and practice. DDN reports

‘Addictions, above all, are a health problem – but they can’t be solved by health interventions alone,’ state secretary to the Portuguese Ministry of Health, Fernando Leal Da Costa, told delegates at the opening session of Lisbon Addictions 2015. Portugal’s groundbreaking policy of decriminalising personal drug possession was one that other countries could learn from, he said. ‘We acknowledge that it’s not perfect, but we do believe that it’s a sensible and rational approach.’

The policy had been fully monitored and the plan was now to further develop it in cooperation with other Portuguese-speaking countries, he said – ‘a way to expand our interventions’. However, Portugal was struggling with the reintegration of people who’d had drug problems, particularly in terms of employment opportunities in the current economic climate, and was aware that more needed to be done in terms of prevention. ‘Much more also needs to be done, Europe-wide, on the issue of alcohol,’ he stated. ‘We need to revisit the alcohol strategy in terms of the whole continent.’

Even defining addiction could present problems, said Robert West of University College London. ‘It’s a complicated subject, with a lot of different components. But we do know that it arises out of learning, which means there’s a huge overlap between neuroscience and behavioural science.’ The question was how to get the best return on investment – not necessarily in monetary terms, but in terms of benefit to society, he said.

Conference 1There was a tendency for people in the field to compartmentalise their favourite model of addiction, he pointed out, whether that related to ‘reward, self-medication, relief from withdrawal, habit, acquired drive’ or other models. ‘All of them have some validity, and in terms of interventions we can educate, persuade, coerce, incentivise, enable, restrict and more. They’re broad-brush things, but all will be relevant at some point.’

For any behaviour to occur, three things had to be in place, he said – capability, motivation and opportunity. ‘So if we do ever manage to crack the problem of addiction, that would be quite a scary thought – it means someone will have a very powerful behaviour-change tool at their disposal.’ Policies and interventions could be informed by neuroscience, he said, and it was now time for a ‘major review of the research strategy underpinning the approaches we take to combatting addiction. I don’t mean a bunfight about where the money goes – just an analysis of how we do it.’

‘There are many levels of ongoing research that are essential to understanding addiction and effective interventions,’ added neuroscientist Marina Picciotto of Yale University. ‘But we do need research that determines the efficacy of the interventions out there.’ One example was Alcoholics Anonymous, she told delegates. ‘Are there options that aren’t being used because there’s this dominant paradigm?’

Neuroscience research had permeated the study of addiction, and public policy, to the extent that it was now ‘practically invisible’ she said, and had been highly successful in developing new interventions. ‘It can identify the primary molecular targets for drugs of abuse, as well as defining circuits, neurotransmitter systems and the really long-term changes that can explain cue and use and so on. It’s even defined the exact molecules in the brain that nicotine binds to.’

However it was important to remember that neurobiology and holistic approaches were not mutually exclusive, she stressed. ‘We do need hybrid neurobiological and behavioural interventions based on what we know about neural systems, and we need to get beyond the “one pill will fix it” philosophy.’

‘The world is a very complicated place,’ agreed Robert West. ‘It’s about finding the right angles to approach things from.’

On the issue of whether treatment was even the correct first response to addiction problems, Mark Kleiman of UCLA’s Luskin School of Public Affairs told the conference that ‘most people who use habit-forming substances do not go on to form bad habits, with the exception of nicotine. With all other substances, rates from initiation to problem use are low. Addiction is not a characteristic property of the use of addictive materials, and I’d also say that most people recover spontaneously – that is, without formal interventions.’

However, spontaneous recovery was usually a reaction to outside events, he stressed – ‘getting a job, pressure from loved ones, things like that. Most people who seek help do so through voluntary self-help programmes such as AA, and the outcomes tend to be just as good as paid treatment. So if you’re a clinician the people you’re going to see are those who didn’t recover spontaneously. But spontaneous recovery is based on a range of external conditions, so we need to make sure the right external conditions are in place.’

This was very different from addiction being a chronic relapsing disorder, he argued, ‘so when we require treatment of someone who’s been arrested for drug possession, for example, we’re making a mistake that can start a cycle of unjustified and ineffective punishment. Involuntary treatment should not be a first resort, as it is in too many cases. If one definition of addiction is to continue to use in the face of adverse circumstances – for example, very intense enforced treatment – then your diagnosis is made. In the US a very large percentage of people with drug problems are under criminal supervision.’

However, the outcomes of treatment were ‘multi-dimensional’, he said. ‘One way to think about treatment is to think about the other problems that people have – treatment should be measured by overall outcomes, not just drug outcomes. The goal should be achieving the best available outcomes for people with substance problems, and the people around them, by whatever means.’

Conference 2‘Do we need treatment as a first response? Yes,’ countered Gabriele Fischer of the University of Vienna. ‘It reduces deaths, reduces use, reduces HIV and HCV risk and saves money. Some say, “why spend the money when people relapse?” Well, relapse isn’t limited to drug treatment – it also applies to the treatment of chronic conditions like diabetes, asthma, hypertension. And when people talk about dependence on methadone, remember that people are also dependent on drugs for diabetes, asthma, hypertension. What’s unique in our population is the percentage of people who are ending up in the criminal justice system.’

In terms of whether those polices would change, Mark Kleiman told the conference that, ‘I’m sure cannabis will be fully legalised in the US in ten years. But I’m only moderately happy about that. If you were going to pick a country to legalise cannabis in you wouldn’t choose one where the courts had ruled that any legal activity can be advertised and promoted without limits. I think we will lurch from prohibition – which admittedly doesn’t work – to the most extreme version of legalisation, and you only have to look to alcohol to see the model for what we’ll have.’

When it came to whether academics should even try to influence policy, views varied, said Linda Bauld of the University of Sterling. ‘It’s very context-specific, and we have to show that there’s a positive impact on society or the economy.’ A great deal had been written about the gaps between research and policy, she said, and addictions research often responded to policy ambiguity by ‘trying to improve the supply of evidence – but that tends to ignore the importance of other factors. It’s very often a long game.’

Alcohol policy was a case in point, she said, where research findings came up against the power of the drinks industry, government indifference, media hostility, low levels of public awareness and other factors. ‘So research alone isn’t enough, but being an advocate for the evidence certainly helps.’

Research into new psychoactive substances (NPS), however, had helped to both inform policy and practice and challenge myths, said Felix Carvalho of the University of Porto. ‘Those myths included that NPS are safer than street drugs, contain fewer contaminants and are associated with lower health risks – general addiction pathways are the same.’ However, researchers tended to publish their findings in scientific journals, he said. ‘And politicians don’t read those. So we do need the mass media.’

Things had changed dramatically for people with addiction issues in the US over the last few years, said former White House ‘drug czar’ Keith Humphreys, now at Stanford University’s School of Medicine (DDN, June 2012, page 16). The 2010 Affordable Care Act – or ‘ObamaCare’ – had defined mental health and substance use as an ‘essential healthcare benefit’, as well as allowing parents to keep their children on their private insurance plans until the age of 26 – and ‘almost all substance use problems have an onset early in life,’ he said. ‘So access to, and insurance coverage for, substance treatment has never been better in the US.’

This meant the law was driving the integration of previously ghettoised specialities into the mainstream, ‘where they belong’, he said. ‘But is science supposed to define policy by itself? Science is very good at identifying emerging problems, and it can also suggest new polices and determine whether existing policies are working. But it can’t tell us what we care about.’ Ultimately, politicians had to make value judgements, he said. ‘You can’t fund everything. Just because we’re experts in science doesn’t make us experts in government.’

The main routes through which findings eventually translated into policy were media coverage, professional and grass-roots organisations, scientists engaging the bureaucracy – both formally and informally – and scientists in policy-making roles themselves, he said.

‘US healthcare policy around substance use has changed dramatically. Scientists did not cause that to happen – they shouldn’t expect to, and no one should expect them to. But when you have political will combined with good research and evidence – that’s when you can really make a difference.’

Potent cannabinoid use

Adam Winstock

Reinventing cannabis

Why are ‘risky’ and ‘unpleasant’ new versions of cannabis replacing the real thing? Adam Winstock shares findings from the Global Drug Survey.

For the last decade much about harm reduction for cannabis was pretty straightforward. Nothing much had changed apart from the dominance of high potency herbal cannabis and its association with higher rates of paranoia, memory loss and dependence.

Then a few years ago things changed with the reappearance and remarketing of hash oil and the emergence from underground laboratories of myriad synthetic cannabinoid compounds. Both have been driven by the potential for huge financial gain, with hash oil riding on the back of the legitimisation – through medicine – of cannabis and the convenient appearance of vaping technologies, and synthetic cannabinoids exploiting a gap in the market for an unregulated cheap ‘stone’ in the face of very expensive herbal cannabis.

Butane hash oil (BHO, also known as shatter, honey and wax) is a new potent form of cannabis with THC of 60-80 per cent (and varying levels of CBD) that has seen a huge rise in popularity in the USA in recent years, driven by a demand among those with medical conditions for preparations that could minimise smoking-related harms and facilitate easier consumption. So just like the synthesis of opium to morphine, the movement to create a stronger and more potent form of cannabis might have therapeutic value.

These concentrations might also carry harm reduction benefits (eg smoking less combustible product, promotion of oral use, less consumption of unwanted impurities), which could extend to the non-medical use community. The development of a more potent form of drug is often partnered with a more efficient route of delivery. In the case of BHO the rapid evolution in ‘vape’ technology has been the perfect accompaniment.

Global Drug Survey (GDS) has been researching the use of natural cannabis preparations and the emerging issues associated with synthetic cannabis products for the last five years. Since 2012 we have collected data from over 150,000 cannabis users and have used this huge pool of expert knowledge to produce a range of free, peer-led harm reduction and self-assessment tools. These include the cannabis drugs meter www.drugsmeter.com, where you can compare your use with 100,000 others; the highway code, www.globaldrugsurvey.com/brand/the-highway-code (the first guide to talk about the impact of various harm reduction strategies on risk and drug-related pleasure), and the world’s first safe-use guidelines for cannabis at www.saferuselimits.com. All of these tools support our aim of making drug use safer, regardless of its legal status.

More than 2,500 users of BHO took part in GDS2015 and we found that BHO did indeed allow the use of non-tobacco routes of administration. Overall, most effects of BHO were reported to be stronger, last longer, and take effect more quickly than high potency herbal preparations. In terms of risks of dependence and withdrawal, most users reported little difference. As ever, it may be that the risks of harm rest in the unique interplay of drug preparation, individual user and their motivation for use.

CabbinoidsBHO is not the only potent cannabinoid product out there, however. GDS has been fascinated by synthetic cannabis and surprised at how such an ‘unpleasant’ drug has flourished. We’ve been researching them since 2010 and have found that synthetic cannabis (SCs) products are far less desirable (93 per cent prefer the real thing) and more risky than natural high potency weed, with the risk of seeking emergency medical treatment at least 30 times higher.

But this doesn’t take account of the massive profits to be made in flogging a cheap high. With emergency room presentations in some US states exceeding that of traditional drugs, and many UK prisons reporting high rates of inmate use and severe complications, it is fair to say that SCs are going to be more than a little challenge to regulators, law enforcement and health providers.

Unlike THC, SCs are full receptor agonists – meaning that there is no ceiling on how stoned you get. Manufactured with varying quality control, dosing is with varying amounts of active product being found on each gram of inert herbal material. Many SCs are much more potent (sometimes hundreds of times more) than THC, and SC products contain no counter-balance such as CBD.

The laws of common sense and basic economic theory (there are lots of natural weed supplies in the world) would suggest that the market for SC products should be dying. And yet they represent the fastest growing group of novel psychoactive drugs reported to international monitoring agencies like the EMCDDA. One reason is that when one set of synthetic cannabinoids is regulated, there’s a whole truck full waiting to be dissolved in acetone and sprayed on damiana and lettuce leaf, dried, packaged and sold for huge profits with no need for elegant hydro set-ups, electricity and water.

But why is there still demand? Why use a less desirable product when a preferable one is usually available? At least in some cases, it will be to avoid workplace drug screens. Working in a prison, I know these products have had real currency, and the same could be said for those in transport, mining and other risk-critical areas. But it’s not just avoidance of detection that can be an issue – it’s also price, potency and bang for buck, because over the last decade, high potency weed has increased in price relative to other drugs in many parts of the world. At a mean price of around €10/gram (and most people getting three to four joints out of gram), pot smoking has become an expensive habit.

For some people, using a more potent but less desirable product might just be down to economics. I bumped into a guy in a head shop in London, who was buying 3gm of cherry bomb for £25. I asked ‘wouldn’t you rather smoke some nice weed?’ ‘Yeah,’ he said, ‘I’m a weed man, but I only get three spliffs from a gram. I can get 25 spliffs out of this. I use it to sleep – saves on my use ofnice weed.’

Two minutes later in walked a mother in her mid-30s with her nine-year-old son: ‘I’ll have the usual – three blueberry bags please.’ So it is out there and people are using it. And sometimes users end up in the ER room, agitated, sweaty, paranoid and psychotic.

I also worry that, given all we know about the harms of early onset cannabis use impacting on the developing brain and increasing the risk of schizophrenia, use of SCs by young people might be a real public health issue. I have to remind them, ‘before you try and expand your brain, you have to let it grow.’

This year GDS is continuing its assessment of synthetic cannabis products. We’ll be looking at the risks of getting dependent, whether or not people get withdrawal, and whether vaporisers and potent new preparations are leading to a whole new range of health risks – or benefits.

Dr Adam Winstock is the founder of Global Drug Survey and a consultant psychiatrist, addiction medicine specialist and researcher, based in London.

To contribute experiences to GDS2015, visit https://www.globaldrugsurvey.com/GDS2015

More information at the GDS YouTube channel: http://bit.ly/1OBLjxW

DDN October 2015

October DDNIn this month’s issue of DDN…

‘Why use a less desirable product when a preferable one is usually available?’

In the October DDN, Adam Winstock explores the reasons why people are attracted to ‘risky and unpleasant’ new forms of cannabis.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page. 

PDF Version / Virtual Magazine

DDN Help 2019

We are currently updating DDN Help and adding more resources. 

Please bear with us.

In the meantime please contact ian@cjwellings.com with any queries.

Minimum pricing ‘could breach EU law’

The Scottish Government’s plans to introduce minimum unit pricing for alcohol could potentially breach EU free trade laws, according to an initial ruling by European Court of Justice advocate general Yves Bot. While the move would not be precluded by EU legislation, it would be legal only if it could be proven that it was the most effective public health measure available, he stated. The decision has been seen as a significant setback to the government’s plans.

In the case of The Scotch Whisky Association and others versus the advocate general for Scotland, Mr Bot ruled that ‘in order to pursue the objective of combating alcohol abuse, which forms part of the objective of protecting public health, a member state can choose rules imposing a minimum retail price of alcoholic beverages – which restricts trade within the European Union and distorts competition – rather than increased taxation of those products, only on condition that it shows that the measure chosen presents additional advantages or fewer disadvantages by comparison with the alternative measure.’ Increasing taxation would be ‘capable of procuring additional advantages by contributing to the general objective of combating alcohol abuse,’ he stated.

Scottish first minister Nicola Sturgeon, however, has stressed that the legal process is still ongoing and that a final response from the European Court of Justice is needed before the case can return to the Scottish courts. ‘This initial opinion indicates that it will be for the domestic courts to take a final decision,’ she said.

‘While we must await the final outcome of this legal process, the Scottish Government remains certain that minimum unit pricing is the right measure for Scotland to reduce the harm that cheap, high-strength alcohol causes our communities,’ she continued. ‘In recent weeks statistics have shown that alcohol related deaths are rising again and that consumption may be rising again after a period of decline. We believe minimum unit pricing would save hundreds of lives in coming years and we will continue to vigorously make the case for this policy.’

Opinion of advocate general at http://curia.europa.eu

Reducing the supply of high strength alcohol

Drink smart

DDN hears about the results from three city-wide schemes aimed at reducing the supply of high strength beers and ciders

Reducing The Strength IpswichIpswich

Simon Aalders, public health engagement manager, Suffolk Public Health

The Ipswich ‘reducing the strength’ scheme was piloted in 2011, then launched in September 2012. Ipswich had 75 street drinkers and 40 per cent of violent crime was alcohol-related. Street drinkers were involved in almost daily call outs for anti-social behaviour. There were four murders in 18 months within the group, and street drinkers were suffering ill health from high alcohol consumption.

The Constabulary, East of England Co-operative Society, Ipswich Borough Council, Suffolk County Council, homeless charities, drug and alcohol treatment agencies, street drinkers and the community have been essential to the campaign. The Licensing Committee supports the voluntary nature of the scheme and considers evidence regarding breaches of licensing conditions.

Successes in Ipswich 

By December 2014, 100 out of 148 alcohol retailers in Ipswich had signed up to ‘reducing the strength’, up from 53 at launch. The East of England Co-op was a trailblazer, removing products above 6.5 per cent ABV. They experienced no loss of income.

By March 2015, the street drinking group reduced from 75 to 14. Many accessed treatment, accommodation or returned to their local area. Antisocial behaviour dropped by up to 75 per cent. Crime is almost non-existent amongst the group. Our evaluation reports shows no loss of income for local traders who have signed up.

The key principles to success are: increasing enforcement; reducing supply; and improving routes out of street drinking.

Lisa’s experience
Lisa is 39. After her mother died, her marriage broke down. She became alcohol-dependent and homeless. Her sons were taken in by family. Lisa was drinking three litres of super strength cider or ten cans of super strength lager everyday. Lisa developed diabetes, her liver function worsened and she has an alcohol-related skin condition.

With treatment and support, Lisa achieved sobriety. She was housed and attended a NORCAS recovery programme, supported by the Anglia Care Trust and the police. She re-established contact with her sons.

‘I fully support ‘reducing the strength’. I was drinking huge quantities to block out my pain. I don’t want other people to suffer the serious effects from super strength alcohol. It can ruin your life,’ says Lisa.

Challenges in Ipswich

One retailer had many street drinkers as customers. Despite shoplifting and abuse, he resisted the scheme fearing loss of earnings. He was observed breaching his licensing regulations, selling alcohol to intoxicated people. He agreed to a voluntary removal of cheap strong alcohol, resulting in reduced disturbance and no profit loss.

The main challenge now is that people think the problem is solved. The worst outcome would be for Ipswich shops to stock these products again, leading to an increase in street drinkers. We have established the Start Afresh group to maintain momentum.

 

Sensible on Strength BrightonBrighton

Jesse Wilde, senior business and partnership manager, Equinox Brighton

‘he Brighton ‘sensible on strength’ scheme started in November 2013. The worst hotspot had up to two-dozen street drinkers, with incidents of anti-social behaviour. Equinox Brighton’s street drinking audit in July 2013 counted 93 street drinkers over one week. Before ‘sensible on strength’, we regularly saw people consuming alcohol up to 9 per cent ABV.

The key partners are Brighton and Hove City Council public health, Equinox Brighton, Sussex Police, street drinkers and alcohol retailers.

Since the launch, St James St MACE have reported a ’better working environment, increased profits and new customers who had previously been put off’. Sainsbury’s and the local licensees association are part of the Alcohol Programme Board and have been supportive.

Some other national chains have resisted the scheme because the products are legal. We are now at a critical point in Brighton, where many retailers have signed up, but some key off licences are holding out.

Tim Nichols, head of regulatory services, Brighton and Hove City Council public health

Brighton and Hove City Council’s Licensing Authority launched ‘sensible on strength’ to reduce the availability of cheap super-strength beers and ciders. We now have 123 retailers signed up.

82 per cent of high profile street drinkers have moved to alcohol below 6 per cent ABV. More clients are engaging with treatment centres, and the scheme is breaking up hotspot drinking areas. We have received significant positive feedback including from businesses on improved trading environments and from health professionals.

Equinox Brighton’s street drinking audit in July 2014 showed a 22 per cent reduction in street drinking since the previous summer. ‘Sensible on strength’ was a key factor in this. 

Dr Tim Worthley, lead GP, Brighton Homeless Healthcare

I care for many of the most entrenched street drinkers. We strive to combat the problems of severe alcohol dependence on the individual and the community. Despite our best efforts, a significant number of our patients die young each year due to alcohol dependence.

I am consistently told by my patients that it is now much harder to obtain high strength lager and cider. Many now drink lower strength alcohol. This has reduced their number of seizures, their ‘confusional state’, and improved their liver function. They are now more able to access general medical care and care specific to their alcohol dependence.

In my professional opinion, ‘sensible on strength’ has been one of the most significant public health measures in Brighton in recent times.

 

Reducing the Strength PorstmouthPortsmouth

Robert Anderson-Weaver, community safety project officer, Portsmouth City Council

Portsmouth’s ‘reducing the strength’ campaign launched in November 2013. Groundwork started in September 2013, including a research questionnaire sent to all Portsmouth off licences.

In Portsmouth, there were two main factors:

  • Street drinking and associated anti-social behaviour – on one Portsmouth road, for example, over 100 incidents were attributed to street drinkers in one month.
  • Health and wellbeing – approximately 40,000 people in Portsmouth were drinking above the recommended units. Portsmouth has one of the highest rates of alcohol-related hospital admissions in the south, costing an estimated £74 million annually, with £10 million NHS spend on alcohol harm.

The Safer Portsmouth Partnership and Police licensing unit have taken the lead with ‘reducing the strength’, directing the campaign at the worst affected areas. They include alcohol nurses, paramedics, licensing practitioners, community wardens and police.

Successes in Portsmouth 

There are 184 off licences in Portsmouth. Over 100 retailers have signed up. In some stores, this means removing one product, often targeted for theft. In others, it’s much higher. One retailer removed 17 products to reduce street drinkers and aggressive beggars targeting his store.

Overall, street drinkers decreased by 39 per cent over 12 months. This shift resulted in a 43 per cent drop in incidents associated with street drinkers, with some individuals seeking help. Four have been the focus of ASBOs, breaking up problem groups.

The campaign’s effects have been especially visible in areas where street drinking was most prevalent. In Cosham, street drinking incidents dropped by 81 per cent. In Albert Road, where aggressive begging was occurring daily, we have seen a 50 per cent reduction. A survey of 25 alcohol-dependent clients, conducted by the alcohol intervention team, found 60 per cent would find it easier to quit if super-strength alcohol was less available.

The public response to the campaign has been excellent. Liver disease is one of the city’s biggest killers. Men are 50 per cent and women 47 per cent more likely to die from the disease than the national rate. Community engagement activities have allowed residents to ask questions about the campaign and show support for retailers who remove super-strength products. This has been a great opportunity to educate the public on unit intake.

Another breakthrough happened in 2014, with a large high street retailer removing super-strength products from over 20 Portsmouth stores.

Challenges in Portsmouth

One retailer sells a 7.5 per cent white cider cheaper than anywhere in the city: £7 for six litres (approx 45 units). This is 16p per unit, almost three times cheaper than health experts recommend, the equivalent of 45 shots of premium whiskey.

Despite shoplifting and health harms, staff say the company would never remove this product due to sales. Their Portsmouth stores are in impoverished areas, with the Cosham store on a street with the largest amount of street drinking incidents in the city. We have shared evidence of problems near their stores, but they see the scheme as penalising responsible drinkers.

The alcohol industry also sees the scheme as penalising responsible drinkers. We have invited producers, manufacturers and distributors to come and see our work to reduce alcohol harm, to show we have a thorough approach to conventional treatment-based initiatives. Not all strong alcohol is targeted by ‘reducing the strength’, just the products found at scenes of crime and disorder.

The challenge now with ‘reducing the strength’ is to achieve consistency across Portsmouth, encouraging even more retailers to sign up. The campaign remains voluntary and issues with competition law hinder communication with the trade as a whole.

For further information or to contact the Ipswich, Brighton or Portsmouth teams delivering these schemes, please email Charlotte Tarrant at Equinox Care: charlotte.tarrant@equinoxcare.org.uk.

Sport in recovery

Pat Berry Ron BellGood sports

Pat Berry and Ron Bell talk about how they help service users improve their wellbeing and build self-confidence from exercise

Playing sports on a regular basis requires discipline, which builds much needed structure into daily life. Being part of a group of like-minded peers, and the natural high gained from exercise, may help raise self-esteem – a key component of good social interaction.

The relationship between sport and improved mental and physical wellbeing is well established. The key is to get people with complex care issues to participate in these positive activities.

The uniqueness of Sporting Recovery is the combination of team and individual sporting activities and lifestyle advice (SMART Recovery) along with the opportunity for clients to gain nationally recognised sports qualifications. As an evidence-based exercise programme, we support adults on their recovery pathway back into their communities.

We focus on people who are marginal, high risk and hard to reach, who often have concerning co-morbidity problems. These adults have difficulties accessing, trusting and re-engaging with traditional services.

The hardest part of any exercise course is starting, particularly when you’ve been inactive for a prolonged period. To overcome this inertia, our programmes are available in the form of transferable season tickets, with the first six sessions free to encourage participation.

We are keen to support successful treatment completions and recommend that service users attend the exercise programme for 42 sessions. The sessions are weekly and include a free lunch, with the opportunity to obtain voluntary and paid work within, and outside, Sporting Recovery.

We believe that if we provide a safe, friendly and fun environment we can engage these hard to reach adults. The first thing is to treat them like regular people with the same desires to enjoy and succeed in their chosen sport. The focus is on self-development and inner peace – something we all need!

Pat Berry and Ron Bell run Sporting Recovery, www.sportingrecovery.org.uk

Drug poisoning deaths highest ever

Drug poisoning deaths hit highest level ever

Last year saw England and Wales register the highest number of drug poisoning deaths since records began more than two decades ago, according to figures from the Office for National Statistics (ONS).

There were 3,346 drug-poisoning deaths registered in 2014, almost 70 per cent of which involved illegal drugs. The figures came just over a week after Scotland also recorded its highest ever number of drug-related deaths for the same period (DDN, September, page 4).

Deaths involving heroin and morphine increased sharply between 2012 and 2014 – from 579 to 952 – while deaths involving cocaine also jumped dramatically, from 169 to 247 in the space of a year. Cocaine-related deaths have now increased for three years in a row, reaching an all-time high of 4.4

per million population. However, while England saw a 17 per cent increase in its drug misuse mortality rate – to 39.7 per million population – Wales saw its proportion drop by 16 per cent to 39.0 per million, the lowest figure for almost a decade.

In England, the north east had the highest mortality rate and London the lowest. As was the case in Scotland, most deaths occurred among older people, with the highest mortality rate in the 40-49 age group, followed by those aged 30-39.

Treatment charity Addaction said the stark figures meant the government now needed to rethink its proposed cuts in local authority health spending (DDN, September, page 4). ‘Drug treatment services across the country have seen an increase in the number of people seeking help for opiates and/or crack cocaine, and this is only likely to increase further as the effect of increased opiate availability and purity is felt,’ said chief executive Simon Antrobus. ‘Meanwhile, the Department of Health are proposing a £200m reduction to the public health grant, which will hit the capacity of drug services commissioned by local authorities.’

The government needed to ensure local authority health spending was given the same amount of protection as that promised to NHS-commissioned services, he stated. ‘The stakes are simply too high to do otherwise.’ 

Deaths related to drug poisoning in England and Wales, 2014 registrations at www.ons.gov.uk

Changing negative behaviours in treatment

Promotional feature

Peter BentleyChallenging attitudes

A decade of experience has shaped Intuitive Thinking Skills’ successful approach to attitude change, as Peter Bentley explains

In 2003, I was coming to the end of a week-long alcohol detox in Manchester’s Smithfield Centre. I was determined to never return there and it was apparent to me that the best way to ensure that was to stop drinking and using drugs for good.

I got a fabulous detox, professionally delivered and with a refreshingly short waiting time to start. What happened afterwards however was far less impressive.

Newly detoxed, I leapt into the post-detox services that were available in 2003. These were pretty much exclusively the fellowships and a kind of quasi fellowship daily support model. There was a unifying thread that ran through all the services then – namely that you were a patient, that ‘treatment’ would take a long time and that there were no guarantees. This was when I was first told that I had a ‘relapsing condition’, that people rarely conquered the problem and that I should not give myself a hard time if I failed.

What was happening in front of my very eyes was the state trying to replace substance dependency with service dependency, and to this day I have proudly railed against the duplicity of this.

So here we are, ten years on, and in May 2015 Intuitive Recovery changed its name to Intuitive Thinking Skills to celebrate its anniversary and to reflect on the increased number of courses we deliver across the UK.

We realised our speciality was attitude change, whatever that attitude may be. Dependence is a curious word, often used to justify the place that a person is in rather than the solution to help move them on. All our courses are designed to enable a person to gain independence – not just from their own negative behaviours but also from public services they are engaged with.

We believe we are a truly unique organisation, entirely peer-led and promoting abstinence, education, training, employment and self-determination within our learners. The fact that we have been there and got the t-shirt means that we deliver hard-hitting, no-nonsense education which cuts through the treatment and recovery jargon that has become so prevalent.

Our staff are all graduates of our programmes and have left services, fully ‘recovered’, employed and enjoying the world of work and all the benefits it brings.

The message? Change looks and feels great and is entirely do-able.

Beliefs

Whether it is beliefs and attitudes that support future substance use, inactivity in employment and education, or negative attitudes to community engagement, our programmes all target these beliefs, presented as negative thoughts, outlooks and attitudes and allow learners to see that they create their own obstacles through their learned thought patterns.

Once people learn that we all have negative thoughts and that we are all selective in choosing which of these we act upon, change becomes easy. After a little practice, the new set of choices becomes second nature.

 

Our programmes

Intuitive Recovery

An accredited educational programme that promotes abstinence as achievable and easy to maintain. Delivered over six sessions, it provides skills and tools to recognise and control addictive desires and to take responsibility for choices, behaviours and change. Install a plan to never use again; it feels great to know you will never go back.

Skills-Tu Employment

Our accredited educational course designed to skill people into employment. The course targets atti­tudes of dependence on state benefits and low or unrealistic aspirations regarding future employ­ment. We deliver in a classroom setting over a short yet intensive period with follow-up sessions supported by sensible yet challenging targets.

Thinking Comm-Unity

Thinking Comm-Unity is an educational course aimed at improving any individual’s knowledge, sense of belonging and understanding of their community. By recognising and valuing each person’s skills and abilities, we demonstrate how these can be coordinated to give people the power and responsibility for their future.

The course helps to identify how attitude, knowledge, skills and abilities can affect not only your life but the lives of those around you. By examining different types of communities, we gain an understanding of the importance of diversity. Through community-focused personal development, we achieve our goals while overcoming challenges and helping to improve the lives and wellbeing of others.

Key Interventions Tools

KIT training offers a simple and effective tool aimed at complementing or refreshing the knowledge and skills of professionals, volunteers or mentors. In fact this is for anybody wishing to gain insight and wanting to improve their work with individuals involved within drugs and alcohol, back to work, criminal justice and social housing sectors. The key objectives of this training are to both raise insight and awareness and encourage independent action towards abstinence, desistance, rehabilitation and employment. Partnership focused, we bring together key stakeholders within an area and look at how system-wide structures can cause blockages and obstacles for our shared service users.

Peter Bentley is managing director at Intuitive Thinking Skills

For more information, visit www.intuitivethinkingskills.com or email info@intuitivethinkingskills.com

Intuitive Thinking Skills – The Specialists in Attitude Change

Drug use in prisons

Promotional feature

Mark NapierA new profile of drug use in prisons

Mark Napier talks to DDN about the emergence of the complex problem of novel psychoactive substances, and some responses that commissioners and providers can adopt to tackle this issue

Health needs assessments

The Centre for Public Innovation (CPI) has been involved in research and supporting the commissioning of substance misuse services since its inception in 2000. The company is a social enterprise with more than a decade of experience working in the field of substance misuse, both with commissioners and providers, helping them to understand their clients and provide better services.

Recently, we completed a series of health needs assessments (HNAs) for a number of prisons, on behalf of NHS England. As with all HNAs, there was much interest among commissioners and prison staff with regard to substance misuse – in terms of the need for treatment and the profile of the drug-using population in prison.

CPI were able to bring together a mix of specialist knowledge of substance misuse treatment, along with in-depth knowledge of how prison healthcare works, alongside robust research skills to help explore the issue of substance misuse.

Novel psychoactive substances

Having completed prison HNAs on many other occasions, the CPI research team were struck by a pronounced shift in the findings on this occasion, as compared to work we had done previously.

From the outset, it was clear that the use of novel psychoactive substances (NPS) was an issue that the HNAs needed to cover. NPS is the catch-all term for a raft of new and emerging drugs that cover ‘legal highs’ to recently banned substances and club drugs.

Prison staff reported concerns about the impact of NPS on the health of prisoners, citing a rise in aggression and other behavioural changes among inmates. Healthcare providers were concerned about the demands that NPS were perceived to be putting on their services as well as the need to send prisoners to A&E following apparent adverse reactions to NPS.

Prison professionals were united in their assessment that the use of NPS was a significant and growing problem that had yet to be fully understood.

The prisoner’s perspective

In consultation with prisoners, there was a clear consensus that NPS were now the ‘drug of choice’ and that their use had overtaken that of other drugs, including cannabis.

Some prisoners interviewed by CPI researchers reported that use of NPS was driven partly by mandatory drug testing. Knowing that NPS could not be detected via existing tests, using NPS enabled them to consume drugs whilst working around the prison system.

What was striking was that, while prisoners were well aware of the use of NPS, they were as unclear about the nature of NPS as prison professionals. Whilst prisoners referred to ‘Spice’ it was clear that this was being used as a catch-all term to describe a range of new drugs with a variety of properties and effects. In essence, prisoners were consuming unknown and untested psychoactives.

Defining the problem

The picture that emerged from the HNAs was of a rapidly changing shift in the use of drugs in the prison but with little hard evidence to determine the impact that NPS were having. Existing systems were not geared to collecting data on NPS. In the absence of data, responses were ad hoc, driven by anecdotal assessments, and lacked a basis upon which to determine what was and what was not effective.

The National Offender Management Service is aware of the issue of NPS and is undertaking research to create a substantive evidence base for use in the prison system, but this work will take some time to report.

What can be done?

Until the NOMS research is available, CPI determined that a number of steps could be undertaken immediately to start responding to the problem:

  • Prison healthcare providers should record any health incident in which NPS is felt to be a causal or associative factor – either where use of NPS is self-reported or determined by health staff
  • Prison healthcare providers should follow Public Health England guidance advising that the appropriate response is to address symptoms rather than the specific drug
  • Substance misuse treatment providers should seek to understand the extent to which their clients are using NPS
  • Substance misuse treatment providers should determine the extent to which existing provision can be adapted to meet the needs of this group of drug users

Understanding about the nature of NPS and how treatment should respond to these drugs is still emerging. The work of CPI can provide some immediate steps that commissioners and providers can consider, while the evidence base develops to determine the nature of the issue and how best to manage it.

Mark Napier is managing director of the Centre for Public Innovation (CPI). For more information about how CPI can help your organisation, visit www.cpi.org.uk or call 020 7922 7820

DDN September 2015

DDNsep2015In this month’s issue of DDN…

‘How is it that a drug with the potential to halve a patient’s risk of dying ends up killing so many people? The answer is horribly simple: while most patients are safer on methadone, the wider population are at continued risk from diverted supplies of the drug.’

In the September DDN, Dave Marteau discusses whether or not it’s time for us to reappraise our relationship with the life-saving drug methadone.

Click on the links below to read more, and don’t forget to join the discussion by commenting, tweeting and liking our Facebook page. 

PDF Version / Virtual Magazine

Drug-related in Scotland

Paul WheelhouseScots record highest number of drug-related deaths ever

 

Scotland recorded 613 drug-related deaths last year, the highest figure ever, according to new statistics from National Records of Scotland. The figure was 16 per cent higher than the previous year, with three quarters of the deaths among males.

The increase comes after a 9 per cent fall in 2013 (DDN, September 2014, page 4), following 2011’s record-high figure of 584 and just three fewer the following year. The average age of those dying from drug-related causes has also continued to rise, and now stands at 40 – 12 years older than when recording began in 1996. Sixty-seven per cent of last year’s deaths were among the over-35s, with just 8 per cent occurring among those under 25.

One or more opioids (including both heroin and methadone) were implicated in almost 90 per cent.

The figures showed that, while there had been some progress, Scotland still faced a ‘huge challenge in tackling the damaging effects of long-term drug use among an aging cohort’, said community safety minister Paul Wheelhouse. ‘This group of individuals often have long-term, chronic health problems as a result of sustained and, in many cases, increasingly chaotic drug-use issues. We need to better understand the needs of particular sub-groups and to better understand what role the purity, or strength, of illicit drugs is playing in increasing fatalities.’

The statistics were confirmation that the outcomes for drug users ‘not engaged in treatment or care’ were becoming ‘increasingly concerning’ added chair of the National Forum on Drug-Related Deaths, Roy Robertson.

‘Older drug users are most susceptible because their often frail health cannot sustain a life of poly-substance misuse, including alcohol use, and injecting-related problems,’ he said. ‘Although the final mechanism of death may be recorded as an overdose, years of high-risk drug use, blood-borne virus infections, smoking and alcohol consumption combine to increase their vulnerability. Stigma, a life course of traumatic experiences, social exclusion and feeling the brunt of austerity leaves many pursuing a risky, hopeless existence, often extinguished ultimately by suffering a drug-related death.’

Drug-related deaths in Scotland in 2014 at www.nrscotland.gov.uk 

E-cigarettes ‘safer than smoking’

E-cigarettes ‘safer than smoking’

E-cigarettes are around 95 per cent less harmful than tobacco and have the ‘potential to help smokers’ quit, according to a new expert independent evidence review published by Public Health England (PHE).

The subject of e-cigarettes has been extremely controversial, with the Welsh Government announcing plans to ban their use in public places earlier this year (DDN, July/August, page 8). However the new report, which PHE is calling ‘a landmark review’, concludes that there is no evidence ‘so far’ that e-cigarettes act as a gateway into smoking for children or other non-smokers.

The review’s authors found that almost all of the UK’s 2.6m e-cigarette users were current or ex-smokers, with most using the devices as an aid to quit smoking. Their use may be helping to contribute to falling smoking rates, it says, with some of the highest successful quit rates found among those who combined e-cigarettes with support from local smoking cessation services. Less than 1 per cent of adults and young people who had never smoked had gone on to become regular e-cigarette users, it states.

While e-cigarettes carry a ‘fraction of the risk’ of smoking cigarettes, they are not ‘risk-free’, says the document. It calls on health and social care professionals to provide accurate advice on the relevant risks, as around half the population are unaware that e-cigarettes are significantly less harmful. The devices could also be a ‘game changer’ in reducing health inequalities, it adds, in that they potentially offer a ‘wide reach, low-cost intervention’ to cut smoking rates in deprived communities, as well as among people with mental health problems.

‘E-cigarettes are not completely risk-free but when compared to smoking, evidence shows they carry just a fraction of the harm,’ said PHE’s director of health and wellbeing, Professor Kevin Fenton. ‘The problem is people increasingly think they are at least as harmful and this may be keeping millions of smokers from quitting. Local stop smoking services should look to support e-cigarette users in their journey to quitting completely.’

‘This timely statement from Public Health England should reassure health professionals, the media, and the public – particularly smokers – that the evidence is clear: electronic cigarettes are very much less harmful than smoking,’ added ASH chief executive Deborah Arnott.

Local news from the substance misuse field

Life Skills EventCornwall service users celebrate life skills

Service users in Cornwall have successfully completed a new accredited course, ‘life skills in action’.

The course, designed by Cornwall Life Skills, offers skills coaching in education, training, voluntary work and employment – such as developing self-confidence and improving interpersonal skills. Course completion leads to a level 1 AptEd award in progression qualification, which is nationally recognised.

A celebration event was held to award certificates to the ten graduates who completed the course, where they were able to share their progress since finishing it. Other attendees were also given the opportunity to enrol with the service.

 

Spectrum earns Purple Star for learning support

Spectrum, a drug and alcohol service run by CRI in Hatfield, has been awarded a ‘purple star’ in recognition of its communication with people with learning disabilities.

The purple star scheme aims to improve relationships between health and social care services and adults with learning disabilities by ensuring all organisations taking part undergo training and service checks to ensure that standards are met.

Spectrum staff took part in specialist training, including how to make their buildings more accessible.

Steve Smith, Spectrum county services manager, said, ‘We are proud of our commitment to support everyone who seeks help to improve their health, or that of a loved one. The purple star award is the result of a proactive effort to make sure all our services are as accessible as possible.’

 

Phoenix kennelsPhoenix residents can bring canine chums to rehab

A block of kennels has been opened at Phoenix Future’s Wirral residential service, Upton Road, to allow service users to bring their dogs along with them to rehab.

The kennels were opened after an increasing number of people with drug and alcohol problems raised concerns that they could not access help as it would mean they would have to give up their pets.

‘Many people in active addiction build strong ties with their dogs. Their dogs keep them warm and safe during periods of homelessness, give them unconditional love through the worst points in their lives and a reason to keep going when all other relationships appear irrevocably damaged,’ says Karen Biggs, Phoenix Futures’ chief executive.

The dogs will be cared for by their owners, trained professionals and others at the service, and the kennels will enable people to live with their dogs while receiving treatment.

 

Naloxone campaign launched in North Somerset

A ‘Keep Calm and Carry Naloxone’ campaign has been launched to help save lives in North Somerset.

Addaction staff in Weston have been offering training on how to administer the life-saving drug, as well as sending participants home with naloxone kits.

The campaign was launched in support of international overdose awareness day on 1 September. ‘Lives will be saved due to this training. Taking heroin is a high-risk activity and our service works hard to show people another lifestyle,’ said service team leader James Brazier.

‘But, while the risk is still happening, users and their significant others should make sure they have a naloxone kit.’

 

Defib trainingOldham project installs life-saving defibrillator

Acorn Recovery Projects have installed a defibrillator at their Brunswick House Oldham centre that will be available to both staff and members of the public.

The ‘defib’ could potentially save the lives of clients, staff and casualties in the wider community, and although no formal training is required to operate it, safety manager Tom Berry delivered training to four Acorn staff at the Acorn Recovery Projects centre.

 

Edgy production in East London

A new production from Outside Edge theatre company uses personal testimonies and live cabaret to explore the ‘splintered, chaotic and at times absurdly comic’ world of people affected by addiction’. Rockston Stories can be seen at Hoxton Hall, east London, from 29 September until 17 October.

The cast have a ‘dynamic creative energy, cutting humour, and an infectious desire to share the truth about addiction,’ said director Susie Miller. http://edgetc.org

 

IMAG0275 bee keeping 3Bee-keeping promotes recovery  

A new bee-keeping project has been launched to promote skills development in Calderdale.

Calderdale in Recovery has received a grant from the Kathleen Mary Denham Fund to purchase hives, safety equipment and the first colony of bees for the project, after the local recovery community was consulted on what kind of project they would like to become involved with.

The aim of the project is to help those taking part develop husbandry skills, with a view to producing ‘recovery honey’ that can be sold to fund local community-led initiatives.

 

 

Benefit sanctions for refusing treatment

Government to consider benefit sanctions for refusing treatment

The government has reignited the debate over whether benefit entitlement should be linked to accepting treatment, with the publication of a new review by Professor Dame Carol Black. Couched in terms of exploring the best ways to ‘support benefit claimants with addictions and potentially treatable conditions’ – such as obesity – back into work, the review will consider ‘the case for linking benefit entitlements to accepting appropriate treatment or support’.

A consultation has been launched to consider the evidence, the results of which will form part of a final report to be published later in the year. Similar plans considered by the last Labour government proved controversial and did not become law.

The independent review will ‘explore the support provided by the existing benefit system and the incentives/barriers created’, says the Department of Work and Pensions (DWP), as well as assess the ‘cost to taxpayers and the economy of worklessness resulting from obesity and addictions’. It will also look at the availability of treatment and study international practice to provide ‘fully costed, robust and deliverable recommendations’ and analysis of the available options.

The review will fully consider the ‘legal, ethical and other implications’ of linking benefit entitlements to the take up of treatment, the government states, and will consult ‘a wide range’ of health and addiction professionals. A steering group will also be established with representatives from DWP, Home Office, Ministry of Justice, Department of Health and others, and the government has said it wants to hear from ‘individuals who have experienced these conditions or any relevant aspects of the health and benefits systems’.

Harmful drinking is estimated to cost around £3.5bn a year to the NHS and £11bn to the criminal justice system, while the review puts the ‘societal costs’ of drug addiction at more than £15bn. Previous research had found one in 15 working-age benefit claimants to be dependent on heroin or crack, says the document, and one in 25 to be suffering from alcohol dependency.

‘Our one nation approach is about giving everyone the opportunity to improve their lives, and for some that means dealing with those underlying health issues first and foremost,’ said David Cameron. ‘Whether it is drug or alcohol problems, or preventable conditions in terms of obesity, support and treatment will be there for you. And we must look at what we do when people simply say no thanks and refuse that help but expect taxpayers to carry on funding their benefits. Over the next five years I want to see many more people coming off of sickness benefit and into work, and Carol Black will report back to me on how best to achieve that.’

An independent review into the impact on employment outcomes of drug or alcohol addiction, and obesity: call for evidence at www.gov.uk. Consultation closes on 11 September.

Psychoactive Substances Bil

Psychoactive Substances Bill must be re-worded, warns ACMD

The Psychoactive Substances Bill should be re-worded to ensure the legislation is effective, enforceable and does not result in ‘serious unintended consequences’, the Advisory Council on the Misuse of Drugs (ACMD) has said. The controversial bill (DDN, June, page 4) is currently making its way through Parliament.

The council has written to home secretary Theresa May to say that while it is ‘supportive’ of moves to prevent harm from new psychoactive substances (NPS) the bill should be reworded to include the word ‘novel’, whADMDich should be tightly defined. The ACMD states that it would support a blanket ban on NPS but cautions against a similar ban ‘on all psychoactive substances’, writes chair Professor Les Iversen, adding that it would be ‘almost impossible’ to list all the desirable exemptions under the bill as it stands. ‘As drafted, the bill may now include substances that are benign or even helpful to people,’ he says, stressing that the ‘psychoactivity’ of a substance cannot be unequivocally proven.

The current bill also ‘uncouples the concept of harm’ from the control of supply, importation and production, despite the expert panel that carried out the original new psychoactive substances review (DDN, December 2014, page 5) recommending a ‘safety clause’ to exclude substances of little or no harm. The bill could ‘seriously inhibit’ medical and scientific research, warns Iversen, and has the potential to ‘both criminalise and apply disproportionate penalties to many otherwise law abiding’ people. Closing ‘headshops’ could also simply displace the market, he says, while those in charge of clubs, festivals, pubs or even prisons could be liable to prosecution.

The ACMD says it is willing to work with the government to draw up lists of substances to be included and excluded and make the sure the bill is enforceable, proportionate and ‘framed using evidence’, but wants to see ‘sufficient resources’ allocated for a ‘thorough, independent’ evaluation of its impacts. It also wants to see ‘social supply’ excluded from the document to make sure that the legislation targets commercial suppliers rather than users. The Home Office has said it will respond to the letter before the bill is next debated in the House of Lords later this month.

Letter at www.gov.uk

National news from the substance misuse field

A round-up of national news – September 2015

Black books

The government has reignited the debate over whether benefit entitlement should be linked to accepting treatment, with the publication of its review by Dame Carol Black. The review will look at the ‘legal, ethical and other implications’ of linking benefit entitlements to the take up of treatment, with a final report to be published later this year.

An independent review into the impact on employment outcomes of drug or alcohol addiction, and obesity at www.gov.uk

Sudden impact

Government plans to reduce the public health grant to local authorities by £200m over the course of the financial year will ‘clearly impact’ on councils’ ability to improve the health of their communities, the Local Government Association (LGA) has stated. ‘Giving councils the ability to make a real impact to the health of local people was a positive step, but local government can only continue its important work such as reducing smoking or excessive drinking and tackling obesity if we are adequately resourced to do so,’ said chair of the LGA’s community wellbeing board, Izzi Seccombe.

Mixed picture

Last year, 38 per cent of 11 to 15-year-olds reported that they had tried alcohol at least once, according to figures from the Health and Social Care Information Centre (HSCIC), the lowest proportion since the survey began. While this ‘downward drift’ was encouraging, however, those who were drinking were drinking more, stressed Alcohol Concern. ‘Looking at the broader picture it’s a case of more alcohol down fewer throats,’ said head of policy Tom Smith.

Choice publication

A booklet on new psychoactive substances and other drugs has been published by Turning Point, aimed at drug users, their families and professionals. The aim is to educate people to make their own choices, says the charity. ‘Substances that are taken in a predominantly recreational context, like novel psychoactive substances, cocaine, steroids and alcohol, place a heavy burden on the health system,’ said director of operations for substance misuse, Jay Stewart. ‘This new guide aims to provide useful information on the risks associated with substances such as these, to dispel some of the myths associated with certain drugs, and to outline the range of support available.’

A useful guide to psychoactive substances, steroids, cannabis and alcohol at www.turning-point.co.uk

New regime

The Care Quality Commission has published a handbook setting out how it will inspect substance misuse services, following a wide-ranging consultation (DDN, February, page 4). ‘Our new regulatory model will put the experiences and views of users of specialist substance misuse services at the heart of how we judge these services, so people can be clear about the quality of services they are receiving,’ said CQC’s deputy chief inspector of hospitals Dr Paul Lelliott.

Download the handbook at www.cqc.org.uk

Prison problem

New psychoactive substances are a source of ‘increasing concern’ in prisons, according to a report from the prisons and probation ombudsman, with links to suicide, self-harm, violence, intimidation and debt. The document looks at 19 deaths in prison between April 2012 and September 2014, where the prisoner was ‘known, or strongly suspected, to have been using NPS-type drugs’. New psychoactive substances at www.ppo.gov.uk

Crops circled

Coca bush cultivation in Bolivia fell by more than 10 per cent last year, according to a UNODC report, with the total area under cultivation down by more than a third since 2010 to the lowest level since monitoring began. The reduction is the result of government efforts to reduce the surplus of coca crops in areas where cultivation is permitted, says UNODC, and to eradicate crops in prohibited areas. Seizures of coca leaf were also up by 22 per cent on the previous year, while seizures of cocaine hydrochloride increased by more 150 per cent.

Coca crop monitoring survey at www.unodc.org

Hep course

A new PHE-commissioned hepatitis C awareness course for people who work with drug users, but who don’t have a medical background, has been developed by RCGP. The free online course takes about two hours to complete.

Find it at elearning.rcgp.org.uk/course/info.php?popup=0&id=175

Giving voice

A new project that aims to ensure that the voices of service users are properly heard is to be headed by ex-NTA chief Paul Hayes. Collective Voice is a joint venture between major service providers including Addaction, Blenheim, CRI, Phoenix Futures and Turning Point. ‘Leadership of this project will require influencing skills, political astuteness and experience of building successful partnerships and links with key stakeholders at the highest level, and the board were clear that Paul Hayes was the outstanding applicant to provide this,’ said a project spokesperson.

 

 

 

 

 

 

 

 

 

Comment from the substance misuse sector

Letters and comment

LettersDDN welcomes your Letters Please email the editor, claire@cjwellings.com, or post them to DDN, CJ Wellings Ltd, 57 High Street, Ashford, Kent TN24 8SG. Letters may be edited for space or clarity.

Game changer

I was brought up in the care system due to my mother committing suicide. Mum was an addict and dad was an alcoholic, so my childhood was pretty messy. By the time I was 13 years old, I had lived with ten different foster carers, including two kids’ homes.

I was running from the pain of my past, hurting others and myself. I was a heavy drug user and always in trouble with the police. I have lived in prison for two years and make no excuses for my crime – however I do believe there is a strong link between crime, addiction and mental health. Before coming to prison I tried so hard to get help, but my funding to rehabilitation was blocked because I was unstable.

While living in prison I have been shocked at the lack of interventions to cure people of crime and drugs. It is too focused on punishment, rather than using the time for great work. More than 70 per cent of people in prison have addiction issues and many suffer mental health problems.

The government drug strategy sets out ambition to tackle substance abuse by building recovery communities within prisons and beyond, but I am saddened at the lack of recovery groups, which could seriously reduce the reoffending rate. Is it really so difficult to start some serious joint working? It breaks my heart to think of men locked in a cell 23 hours a day when we could be using this time to help them – not to mention the annual £40,000 cost to the taxpayer.

Askham Grange is the prison that has changed my thinking and behaviour because staff encourage you to believe you can be a constructive member of society. It has a six per cent reoffending rate compared to the national 60 per cent and was awarded ‘outstanding’ by Ofsted twice within two years. Our prisons should be places where people recover, rehabilitate and move away from crime. The staff here make us realise teamwork is essential in keeping our environment friendly, safe and secure. I feel I now have a future away from crime, drugs and poverty.

The prison has a project called ‘Me, No Way’, where prisoners talk to kids in schools – an emotional experience that really makes you feel part of our community.

We also have a mother and baby unit and the gym courses are excellent – an opportunity that also steers people away from crime and drug-fuelled hostels.

I now have a university degree and would like to develop a social enterprise that employs ex-offenders. Askham Grange has made me believe I am a winner, not a loser, and that I can help others. On behalf of all prisoners, I would like to thank the staff here for seeing us as human beings who have the power to change and become better people.

I hope this letter reaches the eyes of those who have the power to change things. Politicians and commissioners could learn so much from the long-term benefits of Askham Grange.

Paula Wainwright, HMP Askham Grange

 

Where’s the logic?

I’ve just been reading the latest in a long line of letters by Ken Eckersley, CEO of Addiction Recovery Training. In the recent letter (DDN, July/August, page 9) he is onside with Neil McKeganey, calling for ‘regular’ and ‘exhaustive’ drug-testing in UK prisons.

Having worked with class A drug using offenders for over five years it’s clear that something is wrong in our prison system, but I staunchly believe more prohibitive measures are not the answer.

Where does it begin and where does it end? Do you propose testing for every single drug? Because, in my experience, if folk want to use, addict or not, they will find a way. One only has to look at the extensive list of illicit prescription drugs that are currently being used and abused. Or are we to outlaw the use of every pharmaceutical drug too? Prohibition is not a deterrent and I don’t believe it ever truly will be.

It’s a cliché, but change comes from within. Good people can be around that person before they are ready – and good people can be around them when it’s time to help realise that change, but no amount of therapeutic coercion or ‘immediate transfer’ will support that change. I have never heard of demoralisation and lack of autonomy being supportive factors in people’s recovery.

Another thing to note is that when mandatory testing for cannabis was introduced, the fallout was such that many inmates who had never used anything but cannabis in jail turned to heroin, as it left their system quicker. What happened next was they left prison with a heroin habit to feed and, for many, this began the ‘revolving door’ of years in and out of prison. So I fail to see how the proposals are either ‘effective’ or ‘logical’.

Ken ends his letter on a real bum note when he cites China and the US as countries to look to; China with human rights violations galore and the latter being the proud offender of incarcerating more people than anywhere else in the world, many of whom are serving time for non-violent drug offences, with some on life without parole for possession.

For an alternative DVD recommendation please watch The House I Live In and check the logic.

Support don’t punish!

Jesse Fayle, student mental health nurse and former criminal justice recovery practitioner/DIP worker

 

Khat question

What has been the outcome of the UK government’s khat ban? This is an example of the sort of research question that home secretaries like Theresa May are typically uninterested in, and which is therefore far less likely to receive public funding.

By contrast, successive governments encouraged reports that aimed to demonstrate that khat chewing was dangerous and should be banned. When the reports concluded that a ban wasn’t necessary, they waited a bit then commissioned another report. In the end, khat was banned irrespective of research that was ambiguous about the harms at best.

But if the harms were so serious that culturally embedded traditions of British Somalis and Yemenis should be criminalised, it seems equally important to find out whether the policy has been effective and whether these harms have now been reduced. Not to do so might even be construed as a racist oppression of these minorities by the British state.

For example, has khat dependence among the affected adults declined? Or have people just switched to illicit khat, or alternative stimulants that increase harm? Has there been a decline in community cohesion (because khat chewing is traditionally a social activity; not unlike going to the pub for many other British people)? How does the ban mediate the drug-taking careers of second generation Yemeni and Somali youth ie was khat chewing protective against the use of other widely available illicit drugs, or did it provide a gateway to more problematic drug taking?

I have no expectation that these questions will ever be deemed worthy of the sort of public funding considered necessary before khat was banned. But I think they are interesting to highlight, because of the way they add to the evidence that knowledge production is biased towards answers that serve a specific agenda. Bias that – in this case – can contribute to forms of cultural oppression, which might even be relevant to broader narratives on the production of terror.

Neil Hunt, Kent

 

False results

I see that you reported the drug-driving figures from the Institute of Advanced Motorists (IAM) as have other publications (DDN, July/August, page 4). They give the numbers arrested, not charged, and not the number found guilty or not guilty.

At this stage if they have tested presumed positive roadside, they would have a further test to confirm the result.

Are these figures available? They should be – after all, some would have been arrested and put through the courts in March.

My concern is that the initial tests are prone to false results, and in this case it would be false positives. (You will never know of the false negatives!)

David Mackenzie, by email

 

 

Views from the substance misuse sector

Media savvy

The news and views from the national media

Buying ethically produced food, and making a statement about yourself by doing so, is now so easy it requires little or no thought. Thinking about where your narcotics come from, on the other hand, is so difficult it’s simply easier not to do so… We are, it seems, living in the age of the wonky moral compass: of middle-class couples who swear by their weekly organic veg box, and yet relax after dinner with a line of something produced by impoverished, subjugated Bolivian peasants.

Jay Rayner, Guardian, 19 August

Creating a fug of confusion, Public Health England suggests e-cigarettes should be dished out by the NHS, while the Welsh Government says they should be banned in enclosed public places. The Mail believes both are wrong… In different ways, both Public Health England and Labour-run Wales are behaving like nannies. How about treating the public like grown-ups?

Mail editorial, 20 August

The ‘public health’ lobby is a lumbering beast that goes from one extreme to another. If it is not trying to ban something, it is trying to subsidise it. What e-cigarettes and their users really need is to be left alone.

Christopher Snowdon, Telegraph, 19 August

Tobacco is the largest single cause of preventable deaths in England – e-cigarettes may have a part to play to curb tobacco use. But the reliance by PHE on work that the authors themselves accept is methodologically weak, and which is made all the more perilous by the declared conflicts of interest surrounding its funding, raises serious questions not only about the conclusions of the PHE report, but also about the quality of the agency’s peer review process. PHE claims that it protects and improves the nation’s health and wellbeing. To do so, it needs to rely on the highest quality evidence. On this occasion, it has fallen short of its mission.

Lancet editorial, 29 August

Our descendants will wonder if we were ourselves drugged as well as unhinged when, in future times, they mourn and regret our irreversible folly in legalising this dreadful poison [cannabis]. Haven’t alcohol and tobacco done enough damage, and made enough profit for cruel and greedy people?

Peter Hitchens, Mail on Sunday, 23 August

As someone who chooses to not drink, I have become acutely aware of how alcocentric the UK is, and how drinking is consistently tied in with having fun and being happy and relaxed. The predominant message is that alcohol is a prerequisite for letting your hair down and living it up.

Lucy Rocca, Guardian, 12 August

tobacco plain packaging

NeilPlain talk

Has tobacco plain packaging actually worked, asks Neil McKeganey

Since announcing in 2012 that all tobacco products had to be packaged in plain form, bearing large graphic health warnings, but with no brand imagery, the Australian government has been under a legal requirement to provide a review of the impact of the policy.

The clear aim of the plain packaging policy was to reduce smoking prevalence by – reducing the appeal of branded cigarette packs to young people, by removing the brand imagery that might make it that much harder for smokers to quit their habit, and by removing the various logos and colouring that might convey the impression that some cigarettes are less harmful than others.

Siggins Miller, a private consultancy firm funded by the Australian government to contribute to the review, has been carrying out a survey of Australians asking them about their views of plain packaging. But the Siggins Miller review is all about what people think plain packaging may have achieved in changing smoking perceptions, rather than assessing whether it has worked to reduce smoker numbers.

Professor Simon Chapman, one of Australia’s leading tobacco control advocates and a bullish supporter of plain packaging, has stated that plain packaging ‘might well function as a “slow burn”, distal negative factor against smoking, [rather] than as a precipitating proximal factor.’

Dr Olivia Maynard, one of the UK’s leading tobacco control researchers, is now echoing the line being taken by Chapman and others that plain packaging should not be seen as a stand-alone policy in itself: ‘Despite the expected benefits of plain packaging, it is important to remember that it will be most effective as part of a comprehensive tobacco control strategy that includes other policies, such as access to stop-smoking services, restrictions on sales to young people and effective taxation.’

If Chapman and Maynard are right, we may never know what impact the policy has had over and above the other tobacco control measures that have been robustly adopted in Australia. Not knowing whether it has actually reduced smoker numbers will not satisfy countries that are considering whether they too should follow the Australian government in implementing a similar policy.

Neil McKeganey is director of the Centre for Drug Misuse Research, Glasgow

Prescription opioids in the US

Chris FordToo scared to prescribe

Dr Chris Ford finds that in the US, new restrictions have had negative consequences for patients in pain

I was recently discussing the increase in use of prescription opioids in the UK and the US with Alex, an American doctor, who specialises in pain treatment, and I asked whether their new restrictions were helping the situation and was shocked to learn of the negative consequences of these Drug Enforcement Administration (DEA) actions.

He began by telling me about his patient John. ‘John had returned from Iraq in 2013 in a very bad way. He had lost both his legs and part of his left hand, as well as having internal injuries and severe depression. John was very determined and progressed well in rehab, soon became mobile and his mood began to lift. But the thing that didn’t really improve was his pain. He tried everything but nothing helped until we hit on hydrocodone. With his pain under control, John was able to continue his rehabilitation, start a part-time job and even began to play football.’

Then Alex told me the regulations around hydrocodone had changed and so did John’s life. He had always regulated his own intake and sometimes took more and sometimes less, but always within the parameters of the prescription. His pharmacist was ever helpful but was now nervous of the new regulations and wanted John to go to another pharmacy. This unsettled John and he had again become suicidal.

Alex explained further that it is now much harder for him to prescribe opioids, leading to a dramatic reduction in his ability to provide appropriate care for his patients in pain.

In 2014 hydrocodone combination products were ‘rescheduled’ to be like codeine and oxycodone, which were already Schedule II under the US Controlled Substances Act. In the US, there are over 60,000 kg of hydrocodone prescribed a year, a medication that is essentially only available in North America. Primarily available as a combination product, the maximum dose per day has been limited by the amount of paracetamol in the combination. Rescheduling now means that the medicine cannot be called into pharmacies and refills are no longer allowed on a prescription.[1] Additionally, in some states prescribing authority will be limited to physicians, not nurses or physician assistants.

Add to this the increasing restrictions on pharmacies in some states. Many can’t serve their customers who need opioid analgesia because the wholesalers who supply the pharmacy will no longer distribute the amount of medications that is needed. In some areas DEA agents have visited pharmacies to review the quantity of opioids being dispensed. Some pharmacies have reported being warned of increasing DEA review, if the quantity of dispensed medication was greater than the state average. So pharmacies make adjustments to stay in line and that is why John was sent away from his pharmacy. None of this is based on patient need, demographics or doctors but is quite simply a policy developed by bureaucrats, who have no understanding of the problem. Alex has also heard of pharmacists asking patients if they could reduce their dose or change to a non-scheduled alternative. In some cases, patients with advanced cancer have had difficulty filling their opioid prescriptions.

Yet the DEA say they are ‘simply enforcing the law, taking bad people off the street and essentially, trying to interrupt the supply of illegal prescriptions.’ But the agency takes no responsibility about the effect on people who need these medications.

Neither Alex nor I are saying that there isn’t a problem with prescription opioids. But it is complex, and punishing patients who need pain relief is not the solution. There has been an increase in the USA in opioid associated deaths (causality is not often established). However 60 per cent of the deaths are associated with poly-pharmacy (opioids, benzodiazepines and alcohol) and 30 per cent are associated with methadone, although it only represents 3 per cent of pain prescriptions. These deaths are almost all from using methadone as pain relief, not from OST. Some states mandate the use of methadone as a second line opioid after morphine in order to save money, although most physicians have little education in its prescribing.

Concurrently some people who have become dependent on prescription opioids are turning to heroin, which is becoming increasingly available in US. There has been much in the press about this but the increase in deaths is only partially related to this change and more to do with increasing purity of heroin.[2] People then using this heroin-prescription drug combination are not the traditional population of people who use drugs. This problem is increased dramatically among white people and especially among young white men. Eliminating or restricting opioid analgesics doesn’t make the problem of dependency go away.

Khary K. Rigg, Assistant Professor of Mental Health Law and Policy, University of Southern Florida; and Shannon Monnat, Assistant Professor of Rural Sociology, Demography, and Sociology, have recently published on the complexity of this problem and identify three groups of opiate users, who are distinct demographically, socioeconomically and psychologically. While heroin use is typically characterised as being a problem in black, poor and urban areas, an increasing number of people who use heroin and prescription opioids are white, employed and live in rural and small urban areas. The third group they identified are people who are addicted to prescription opioids alone and tend to be the most socially connected of the three groups. This group is the least socioeconomically disadvantaged and have better physical and mental health[3].

Professionals who treat people with drug problems should recognise the unique needs of each group of addicts, according to the researchers.

So what is happening in the UK? Prescription opioid dependence is a growing problem here and best-practice management is as yet not well defined.[4] In 2013, 757 people died with a prescription opioid in their blood stream, almost the same number as for heroin and illicit morphine (765) and more than for methadone (429).[5] It is critical that we understand this problem and respond appropriately, and avoid falling into the trap that the US has set for the people caught up in this situation.

[1] DEA Schedule II rules. http://www.deadiversion.usdoj.gov/pubs/manuals/pract/section5.htm

[4] Bernadette Hard. BMJ, 2014

[5] Office of National Statistics, 2014

Dr Chris Ford is clinical director of IDHDP, www.idhdp.com. Full version at www.drinkanddrugsnews.com

 

Bereavement and addiction

John RossingtonCause and effect

Last issue, we reported on a set of guidelines about supporting those bereaved through drug and alcohol related death. John Rossington looks at how a personal loss can in turn lead to addiction

I have been employed in the substance misuse field for many years and I have always been struck by how often bereavement has been the precursor to a period of active addiction to drugs or alcohol. Two years ago, I was propelled into the nightmare world of bereavement and was given insight into how personal loss and society’s reaction to such loss leaves an individual so vulnerable.

I have never had a family to speak of and for 20 years, I lived with my soulmate Michael. On 9 March 2013, I returned from work in the evening and found him unconscious on the sitting room floor. By 10 o’clock that night he was dead.

In an instant my life had changed completely and I had been tossed into a world of complete isolation. It felt as if the world was embarrassed by my grief and turned its back on me.

When I eventually returned to work, emotionally drained, I was stung by most people’s reactions. It was clear that most of my colleagues wanted not only to ignore Michael’s death, but to wish away his very existence.

We must ask ourselves why we have reached such a state in society where we are unable to engage in each other’s pain and provide comfort to those in distress. If we cannot address this, then many others will mistakenly seek comfort in the oblivion of drugs or alcohol.

Michael’s death and people’s reaction to it have changed me. For the first time in my life outside of work, I am quite reclusive. I worry that I am a nuisance to other people.

There are signs of hope. I am impressed by how so many people in the recovery community are committed to creating meaningful communities where we engage with each other in a supportive and nurturing way.

In the meantime, I take some comfort in the fact that I have not succumbed to addiction and hope that I can be more effective in supporting others for whom profound loss has been the cause of their drug or alcohol issues.

John Rossington is manager at Big Life Pathways Drug and Alcohol Service

CQC inspections

DFinneyGet in gear

David Finney guides you through the new CQC inspections

The Care Quality Commission has just published guidance on the new way in which treatment services will be inspected. The process will be very different from before, because the inspections are now organised by the Hospital Directorate.

The first major change is the introduction of a ‘briefing and planning session’ with an inspector at the outset of the inspection process. This will be an opportunity for you to explain how your service works, and will enable the inspector to plan the site visit appropriately.

At this stage you will also be asked for contact information for your stakeholders, who will be surveyed by CQC. These will include commissioners, local authorities, referrers from drug and alcohol teams, doctors, social workers and care managers.

Then an ‘intelligent monitoring’ phase will start, during which CQC will gather data. Some of this will be provided by you, such as:

  • Outcome data, eg on completion or return to treatment, abstinence rates, safeguarding alerts.
  • Information from service users and the public (usually obtained through surveys).
  • Information from and about staff, eg turnover, stability, sickness rates and concerns raised.

Furthermore, you will be asked questions in a ‘provider information return’, which will include specific questions about:

  • Safety and effectiveness, including serious incidents, DoLS (Deprivation of Liberty Safeguards) or medication errors.
  • Complaints and how governance is exercised (do you learn from incidents and mistakes?)
  • Equality and diversity, ie examples of how it is evidenced, or data to show that specific groups are not discriminated against.
  • How improvements are made in the service.

Another major change is that you will be given a date for a site visit and CQC will seek information about your service in the intervening period. This will give you an opportunity to audit your service thoroughly before the site visit takes place.

At the beginning of the visit, there will be an opportunity for you to give a ‘provider presentation’, in which you can:

  • Outline the background to your organisation. I suggest that you include an explanation of your treatment philosophy.
  • Show that you provide quality care. Demonstrating an understanding of the five key questions (safe, effective, caring, responsive and well led) will be helpful.
  • Demonstrate what is working well or is outstanding. You could focus the success rate in terms of completions and the compliments you have received.
  • Highlight any areas of concern or risk. For example, you could mention any boundary issues such as transition, or any issues you may have with mental health teams.

Then, during the visit, the Inspection team will observe interactions between staff and service users, talk with service users, staff and the manager, and look at some records.

There are actually very few questions in the methodology that are specific to substance misuse treatment. However, those that are include:

  • Identification of drug and alcohol-related harm, and deteriorating health.
  • An opportunity to explain the restrictions on movement usually imposed as part of a treatment programme.
  • The involvement of recovery champions.
  • Processes in place for unexplained or unplanned discharges.
  • The planning of services to take account of people with complex needs or vulnerabilities – such as dual diagnosis, multiple drug use, homelessness, pregnancy, or criminal justice involvement.

Finally, it has now been decided that CQC will not be able to give ‘ratings’ for substance misuse treatment services. This is because they were not included in the list of services given to the Department of Health when drafting the regulations, so CQC has no legal power to provide ratings. This decision applies to everyone in the sector, so no specific group of services will be disadvantaged by it.

The full information about the new inspection process can be accessed at www.cqc.org.uk/content/guidance-providers. I wish you the very best of success in navigating this new system and will continue to update you through DDN as and when new information becomes available.

David Finney is an independent social care consultant. His workshop is on 6 October in London, details at www.drinkanddrugsnews.com/CQCtraining